InteractiveFly: GeneBrief
spaghetti squash: Biological Overview | References
|
Gene name - spaghetti squash
Synonyms - MRLC Cytological map position-5E1-5E1 Function - signaling Keywords - nonmuscle myosin II regulatory light chain (MRLC), cytoskeleton, oogenesis, dorsal closure, wing, eye |
Symbol - sqh
FlyBase ID: FBgn0003514 Genetic map position - X: 6,117,094..6,119,196 [-] Classification - EF-hand, calcium binding motif Cellular location - cytoplasic |
The Drosophila egg chamber is an organ composed of a somatic epithelium that covers a germline cyst. After egg-chamber formation, the germline cells grow rapidly without dividing while the surface of the epithelium expands by cell proliferation. The mechanisms that coordinate growth and morphogenesis of the two tissues are not known. This study identifies a role for the actomyosin cytoskeleton in this process. Myosin activity is restricted to the epithelium's apical surface, which is facing the growing cyst. The epithelium collapses in the absence of myosin activity; the force that deforms the epithelium originates from the growing cyst. Thus, myosin activity maintains epithelial shape by balancing the force emanating from cyst growth. Further, these data indicate that cyst growth induces cell division in the epithelium. In addition, apical restriction of myosin activity is controlled. Myosin is activated at the apical cortex by localized Rho kinase and inhibited at the basolateral cortex by PP1β9C. In addition, these data indicate that active myosin is apically anchored by the Bazooka/Par-6/aPKC complex (Wang, 2007).
To analyze the correlation between cyst growth and follicle cell division, dividing cells in the follicular epithelium were counted. Within the first 56 hr that are required to form a stage 3 egg chamber, cell-division rates are very low. In the 14 hr period between stage 4 and stage 6, however, cell-division rates continuously increase. During this time, the volume of the cyst increases approximately 11-fold. This parallel increase in mitosis and cyst growth reflects how the growth of the inner cyst is compensated by cell division in the outer follicular epithelium. After stage 7, the follicle cells stop dividing and undergo diverse morphological changes (Wang, 2007).
Newly formed egg chambers are round and change their shape to ellipsoid during early oogenesis. After stage 7, the process of egg-chamber elongation, which is mediated by a polarized actin cytoskeleton within the follicular epithelium, starts. Actin fibers at the basal cortex of the follicle cells run perpendicular to the anterior-posterior axis of the egg chamber, and their contraction leads to an axis expansion. The mechanisms that shape the egg chamber before elongation takes place are unknown. The simultaneous and rapid growth of cyst and epithelium after stage 3 indicates that the development of the two tissues is precisely coordinated. It is, however, unclear how epithelial morphogenesis and proliferation are coupled to the growth of the cyst (Wang, 2007).
The actin cytoskeleton is central for the cell shape, and is thus a possible candidate involved in a controlled epithelial response to the cyst growth. The activity in the actomyosin cytoskeleton was examined by using an antibody specific for the activated form of the regulatory light chain of nonmuscle myosin II (RMLC; Spaghetti squash). The phospho-specific RMLC antibody binds to phosphoSerine21 and reveals myosin in its active state. Around stage 3 of oogenesis, myosin activity restricts to the apical cortex of the follicle cells, where it is maintained until late oogenesis. After stage 7, myosin activity is also present at the basal cortex of the follicle cells in the actin bundles required for egg chamber elongation. Optical confocal sections reveal a pattern of myosin activity in these long parallel bundles that is reminiscent of stress fibers. In contrast, at the apical cortex, myosin is active in short fibers with random orientation reminiscent of a web (Wang, 2007).
The membrane domains of the follicle cells are established before myosin activity restricts to the apical cortex at stage 3. To examine how apical myosin activation relates to follicle cell polarity, mutants affecting epithelial polarity were examined. To avoid perdurance of the wild-type protein after clone induction, focus was placed on large clones, or clones spanning the whole epithelium. The adherence junctions are central for the organization of the apical actin cytoskeleton, and the domain of myosin activity extends into the region where they localize. Therefore null mutants of armadillo (arm), which encodes Drosophila β-catenin, were examined. It has been shown that the adherence junctions are disrupted in arm follicle cell clones since neither DE- or DN-cadherin are detectable. As a result, arm mutant cells exhibit strong cell-shape defects. Surprisingly, it was found that myosin activity is clearly restricted to the apical membrane in arm follicle cell clones. Thus, myosin activity restricts apically in the absence of adherence junctions (Wang, 2007).
The apical membrane domain is established by the Crumbs (Crb)/Stardust (Sdt)/Patj complex and the Bazooka (Baz)/Par-6/aPKC complex. All these proteins localize, like pRMLC, to the apical membrane of the follicular epithelium. In epithelia lacking crb, myosin restriction is affected as revealed by the interrupted apical pRMLC pattern and by ectopic activity at the basal membrane. However, apical myosin activity is not completely disrupted as broad regions of the epithelium still concentrate higher levels of pRMLC at the apical compared to the basal cortex. In contrast, par-6, aPKC and baz mutants abolish the formation of the apical myosin activity. In these mutants, apical pRMLC restriction is lost, and ectopic myosin activity is detectable in the cytoplasm and at the basal cortex. To test whether the two apical complexes cooperate in apical myosin restriction, baz sdt double mutants were examined. The phenotype of the double mutants is, however, very similar to that of the baz single mutants, suggesting that apical myosin activity is controlled by the Baz/Par-6/aPKC complex (Wang, 2007).
To further analyze this interaction, the Baz/Par-6/aPKC complex was immunoprecipitated from ovaries using an antibody against Baz. Western-blot analysis of the precipitated protein complex reveals a strong enrichment of Baz and aPKC. Notably, pRMLC is also present in the precipitated protein complex, indicating an association of Baz and active myosin. Taken together, these genetic data show that baz, par-6, and aPKC are required for apical myosin restriction, and biochemical data show that Baz associates with pRMLC. This suggests the Baz/Par-6/aPKC complex anchors active myosin at the apical cortex. To further analyze the role of the complex in the apical restriction of myosin activity, its localization was examined in mutants that affect pRMLC localization. Consistent with a function in the anchoring of active myosin, it was found that apical aPKC localization is not affected in arm mutants, in which pRMLC is apically restricted. Further, apical aPKC localization is interrupted in crb mutants, in which pRMLC localization is also interrupted. In summary, the data suggest that the Baz/Par-6/aPKC complex anchors active myosin at the apical cortex independently of the adherence junctions (Wang, 2007).
To examine how myosin activity is inhibited during early oogenesis at the basal and lateral cortex, the localization and function of PP1β9C, the phosphatase that deactivates phosphorylated RMLC (Vereshchagina, 2004) was examined. In follicle cells, PP1β9C is ubiquitously distributed as revealed by a hemagglutinin (HA) fusion protein. PP1β9C is encoded by flap wing (flw). Western-blot analysis of the viable flw1 allele showed that the total pRMLC levels in ovaries are increased 2.8-fold compared to those of the wild-type. The total increase is the result of ectopic myosin activity in the follicular epithelium. This is revealed by flw6 follicle cell clones and homozygous flw1 mutant egg chambers, which show pRMLC staining at the basal and lateral cortex. Interestingly, the ectopic Myosin activity is accompanied by an irregular and wavy appearance of the apical surface of the epithelium. In addition, flw mutant egg chambers are not round or ellipsoid like the wild-type but are either stretched or develop bulges. The coincidence of the altered shape with the ectopic pRMLC staining in the follicular epithelium suggests that the abnormal shape is the result of ectopic myosin activity. This is confirmed by the finding that the expression of constitutively active RMLC results in a very similar phenotype. The defects in flw mutants are not secondary effects of mislocalization of the Baz/Par-6/aPKC complex as the localization of aPKC is indistinguishable from that of the wild-type. In summary, these results show that PP1β9C activity is required to prevent myosin activity at the basal and lateral cortex. They further suggest that during early oogenesis, myosin activity has to be restricted to the apical cortex to ensure the development of normally shaped egg chambers (Wang, 2007).
To investigate how myosin is activated at the apical cortex, the function of Rok, which has been shown to regulate myosin phosphorylation, was analyzed. Myosin phosphorylation is greatly reduced but still detectable in rok mutant follicle cell clones. This confirms that Rok phosphorylates myosin in the follicular epithelium, but also indicates that Rok is not the only kinase involved in myosin activation. A HA-Rok fusion protein accumulates in particles at the apical cortex of the follicle cells, which are in close proximity to the web-like myosin fibers. Thus, localized Rok activates myosin in the follicular epithelium (Wang, 2007).
Because RMLC phosphorylation is strongly reduced in rok mutant cells, rok clones were used to examine the function of apical myosin activity. rok mutant follicle cells divide normally, form a monolayered follicular epithelium, and retain polarity. However, rok mutant cells fail to adopt a normal shape. As a consequence, the epithelium is flatter in these regions than it is in regions with rok activity. Optical sections at the level of the zonula adherens show that rok mutant cells are also stretched compared to neighboring wild-type cells. Furthermore, egg chambers with large follicle cell clones develop abnormal shapes as the cyst bulges outwards in the area of the clones. These results show that rok is required for follicle cell and egg-chamber shape, and indicate that the function of the apical myosin activity is to prevent flattening and stretching of epithelial cells (Wang, 2007).
To test the function of the apical myosin activity directly, follicle cell clones were generated using a null mutation for spaghetti squash (sqh). sqh encodes RMLC and was previously shown to be required for other aspects of egg-chamber morphogenesis, like cyst separation and follicle cell migration (Karess, 1991; Edwards, 1996). Follicle cells lacking RMLC activity are extremely flat and appear stretched. In many egg chambers with sqh clones, gaps were found in the follicular epithelium, suggesting that stretching of the follicle cells eventually disrupts the monolayer. The flat sqh mutant cells retain polarity, as revealed by the localization of Discs large (Dlg), a marker for the region where the septate junctions are formed, and the localization of the apical marker aPKC. The change in the shape of the follicle cells is accompanied by a change in the morphology of the egg chamber. Although those regions of the egg chamber covered by wild-type follicle cells retain a normal shape, the germline cyst bulges out in regions covered by sqh mutant cells. In summary, the morphological defects in the sqh clones are very similar to the defects in the rok mutant clones, although the sqh phenotype is much stronger. The stronger morphological defects in sqh mutants are consistent with the finding that RMLC activity is only reduced in rok, whereas it is abolished in sqh mutant cells (Wang, 2007).
sqh function is also required for cytokinesis (Jordan, 1997), and, consistent with this, epithelia with sqh mutant clones show a reduced number of phospho-Histone H3-positive cells, huge nuclei, and abnormally large cells. To examine whether these defects contribute to the morphological defects, epithelia with clones mutant for diaphanous (dia), another gene required for cytokinesis, were examined. Using the weak allele dia5, follicle cell clones were identifed showing cytokinesis defects in the presence of a normal actin cortex. During early oogenesis, these clones retain a rectangular shape, do not flatten, and the underlying cyst bulges out only very mildly. Late clones show no outward bulging over the growing oocyte and maintain a normal cell shape, with the exception that the cells are bigger because of the absence of cytokinesis. Thus, cytokinesis defects alone do not affect the rectangular shape of the follicle cells, and they affect the shape of the egg chamber only mildly and only during early oogenesis. Importantly, the morphological defects are fully penetrant in sqh mutant follicle cell clones. It is therefore concluded that the morphological defects in egg chambers with sqh clones are the result of the loss of apical myosin activity (Wang, 2007).
The epithelial deformations in sqh clones suggest a stress that is acting on the epithelium. The outward bulging of the cyst further suggests that the origin of this stress is the volume increase of the growing cyst. Wild-type cells might resist this stress because of the myosin activity at the apical cortex that is facing the cyst, whereas sqh mutant cells collapse. To test this hypothesis, cyst growth was blocked by using a chromosome carrying an ovoD1 mutation. ovoD1 is a dominant female-sterile mutation that is normally applied in germline mosaics. Importantly, the ovoD1 phenotype is restricted to the germline and does not affect the somatic epithelium. The ovoD1 harbouring chromosome that was used in this experiment leads to a growth arrest after stage 4 resulting in small stage 6 egg chambers, which later degenerate (Wang, 2007).
sqh follicle cell clones were genrated in parallel in wild-type and in ovoD1 mutant backgrounds and cyst and epithelial shape was analyzed. Strikingly, sqh mutant follicle cells maintain their rectangular shape when cyst growth is blocked, whereas sqh cells are deformed when the cyst grows. Moreover, the cyst bulges out underneath the sqh clones only in the wild-type background, but not in the ovoD1 mutant cysts. Thus, myosin activity is required for epithelial and egg-chamber shape only if the cyst is growing. It is therefore concluded that epithelial myosin activity counteracts the force from the growing cyst (Wang, 2007).
How could myosin activity counteract stress from the growing cyst mechanistically? In Dictyostelium, it has been shown that the cell membrane is able to resist deformations induced by a cell poker, revealing stiffness of the cortex. In myosin mutants, the cortical stiffness is greatly reduced, indicating that stiffness is generated by myosin-mediated contractions within the actin cortex. Consistent with this, in vitro studies demonstrated that myosin activity increases the stiffness of crosslinked actin filaments by a factor of 100. Stiffness is generated by diminishing thermal fluctuations within a crosslinked actin network. Myosin is able to suppress these fluctuations by mediating contractions of actin filaments between crosslink points. It is proposed that stiffness is a crucial feature of the apical epithelial cortex in response to the stress emanating from the growing cyst, and that myosin regulates the stiffness by generating tension between actin crosslink points (Wang, 2007).
The pattern of myosin activity reflects the organization of the actin cytoskeleton. The stress fiber-like pattern at the basal cortex reveals activity in the parallel actin arrays, and this activity leads to egg-chamber elongation. In contrast to this polarized pattern of myosin, the apical pattern shows no uniform direction, indicating that actin filaments of all orientations contract. This suggests that the actin filaments at the apical cortex are crosslinked like a net. Thermal fluctuations are higher in actin networks compared to bundled actin filaments. A netlike organization of the actin filaments is therefore consistent with the model, in which myosin-mediated contractions increase cortical stiffness by suppressing thermal fluctuations within the net (Wang, 2007).
The follicular epithelium responds to the cyst growth by increasing the epithelial surface by cell proliferation. The signal that induces mitosis is unknown. These data raise the possibility that the actomyosin cytoskeleton is involved in the coordination of cyst growth and epithelial proliferation. It is likely that the apical cortex, which is stiffened by myosin, perceives the volume increase of the growing cyst as a further tension increase in the crosslinked actin filaments. It is speculated that tension increase above a certain threshold triggers mitosis in the epithelium. The resulting cell divisions lead to an enlarged epithelial surface and thereby to a tension decrease at the apical cortex. The coupling of tension increase and cell proliferation adapts the growth of the epithelium to the volume increase of the cyst and prevents epithelial rupture. The role of tension in regulating cell growth was proposed in the past and has been demonstrated recently in cell culture experiments (Wang, 2007).
If cyst growth and epithelial proliferation are coupled, follicle cell division should be reduced when the cyst volume does not increase. Notably, a dramatic reduction was found in cell division in ovoD1 mutant ovarioles, in which growth is blocked. Consistent with this, it has been reported that block of cyst growth induced by germline clones mutant for the Drosophila Insulin receptor and dMyc does not result in excess follicle cells. These results show that cyst growth and epithelial growth are coupled. However, they allow no conclusion about the coupling mechanism (Wang, 2007).
The restriction of myosin activity to the apical cortex of the epithelium is mediated by at least three different mechanisms. First, myosin phosphorylation at the apical cortex is achieved by apical localization of Rok. Rok is also regulated by the small GTPase Rho1. rho1 mutant follicle cell clones show reduced apical myosin phosphorylation and cell flattening, suggesting that Rho1 binding enables Rok to phosphorylate myosin. In contrast to rok mutant clones, rho1 mutant cells have large nuclei and an increased cell size, indicating that Rho1 is also required for cytokinesis. The second mechanism that restricts myosin activity to the apical cortex is the anchoring of active myosin by the Baz/aPKC/Par-6 complex. The third mechanism is the inhibition of myosin at the lateral and basal cortex via PP1β9C-mediated dephosphorylation. In the future, it will be important to find additional components regulating apical myosin activity, and to find out whether myosin activity is also in other epithelia restricted to certain domains (Wang, 2007).
Drosophila flapwing (flw) codes for serine/threonine protein phosphatase type 1ß (PP1ß). Regulation of nonmuscle myosin activity is the single essential flw function that is nonredundant with the three closely related PP1α genes. Flw is thought to dephosphorylate the nonmuscle myosin regulatory light chain, Spaghetti Squash (Sqh); this inactivates the nonmuscle myosin heavy chain, Zipper (Zip). Thus, strong flw mutants lead to hyperphosphorylation of Sqh and hyperactivation of nonmuscle myosin activity. This study shows genetically that a Jun N-terminal kinase (JNK) mutant suppresses the semilethality of a strong flw allele. Alleles of the JNK phosphatase puckered (puc) genetically enhance the weak allele flw1, leading to severe wing defects. Introducing a mutant of the nonmuscle myosin-binding subunit (Mbs) further enhances this genetic interaction to lethality. puc expression is upregulated in wing imaginal discs mutant for flw1 and pucA251, and this upregulation is modified by JNK and Zip. The level of phosphorylated (active) JNK is elevated in flw1 enhanced by puc. Together, this study shows that disruption of nonmuscle myosin activates JNK and puc expression in wing imaginal discs (Kirchner, 2007; full text of article).
This study shows that the nonmuscle myosin phosphatase flw interacts genetically with components of the JNK signaling pathway. The proteins JNK and PP1ß (Flw), as well as the mechanisms of JNK signal transduction and nonmuscle myosin activation, are highly conserved between Drosophila and humans. This suggests that findings of Drosophila PP1ß regulating JNK through nonmuscle myosin may be relevant for similar processes in human cells and tissues (Kirchner, 2007).
bsk (JNK) mutants suppressed the semilethality of the strong allele flw6, while puc and constitutively active hepCA enhanced the weak viable allele flw1, resulting in severe wing defects. The level of diphosphorylated (active) JNK was elevated in a flw1/Y ; pucA251 mutant background. This, together with the finding that puc expression was upregulated in wing imaginal discs of flw1/Y ; pucA251/+, implies that flw can act as a negative regulator of JNK. This was further supported by the fact that puc expression was not upregulated in flw1/Y ; bsk1/+ ; pucA251/+ wing imaginal discs, where reduced amounts of overall JNK (Bsk) protein probably compensate for elevated activity of JNK in flw1/Y ; pucA251/+. A possible difficulty with using pucA251 (or pucE69, another frequently used puc enhancer trap) as a reporter of puc expression is that both lines are also puc mutants, and puc probably regulates its own expression through a negative feedback loop involving JNK. However, it was confirmed in an independent assay with an anti-P-JNK antibody that JNK was indeed ectopically activated in flw1/Y ; pucA251/+. Wing imaginal disc extracts from both flw1 and pucA251/+ showed somewhat elevated levels of monophosphorylated, but not diphosphorylated, JNK. In flw1/Y ; pucA251/+, it is suggested that dephosphorylation of JNK fails to such an extent that JNK is substantially diphosphorylated and thereby activated. Since it has been shown that activation of JNK in wing imaginal discs induces apoptosis, it is likely that the flw1/Y ; puc/+ wing phenotype is due to increased death of cells with aberrantly activated JNK (Kirchner, 2007).
A zip mutant suppresses the upregulation of puc in wing imaginal discs as well as the adult wing phenotype of flw1/Y ; pucA251/+. This shows that nonmuscle myosin acts upstream of JNK and mediates an activating signal on JNK in a flw1/Y ; puc/+ mutant background; this is also consistent with the finding that a mutant in the myosin phosphatase-targeting subunit Mbs enhances flw1/Y ; pucA251/+ to lethality. Drosophila encodes two myosin phosphatase-targeting subunits, Mbs and MYPT-75D. Mbs binds both Flw and Pp1-87B, while MYPT-75D binds Flw specifically Vereshchagina, 2004). Unfortunately, it was not possible to test for genetic interaction between flw1/Y ; pucA251/+ and MYPT-75D because no MYPT-75D mutants have been described. It was also found that a Rho1 mutant abolishes ectopic lacZ staining in flw1/Y ; pucA251 wing imaginal discs. Rho1 is an activator of Rho-dependent kinase, which phosphorylates and activates myosin light chain, as well as phosphorylating and inhibiting Mbs. Furthermore, both zip and Rho1, in combination with other genetic interactors, have been reported to show a malformed third-leg phenotype that resembles that of flw1/Y ; puc/+ (Kirchner, 2007).
Dorsal closure and wound healing depend on both nonmuscle myosin and JNK activity, but a clear genetic or molecular interaction between these pathways has not been previously demonstrated. This is the first study that shows that disruption of nonmuscle myosin can induce activation of JNK, although the mechanism of signal transduction is not clear. The single essential and nonredundant function of flw is the inhibition of nonmuscle myosin activity, presumably by dephosphorylating Sqh at T21 and S22. However, the results suggest that hyperphosphorylation of Sqh at these residues may not explain the elevated expression of puc in flw1/Y ; pucA251/+ flies. Additional mechanisms may exist to regulate nonmuscle myosin assembly and activity through phosphorylation, and the complex Flw/Mbs may have other targets in the actomyosin network in addition to Sqh. For example, moesin and focal adhesion kinase are potential targets for mammalian myosin phosphatase. Interestingly, overexpression of the focal adhesion protein tensin (blistery) in Drosophila wing imaginal discs activates JNK and induces apoptosis (Kirchner, 2007).
Two important questions remain unanswered regarding the results on the activation of JNK through nonmuscle myosin. (1) What is the molecular pathway from nonmuscle myosin to JNK? Several mechanisms have been identified that activate JNK and induce apoptosis in wing imaginal discs. For example, mutations in the caspase inhibitor DTraf1 (Drosophila tumor necrosis factor receptor-associated factor 1), as well as inhibition of DTraf1 by overexpression of Hid (head involution defective), Rpr (reaper), or Grim, induces JNK-mediated apoptosis, possibly through Msn (misshapen) or Ask1 (apoptosis signal-regulating kinase 1). Other factors involved in inducing apoptosis and activating JNK are Eiger (Drosophila tumor-necrosis factor superfamily ligand), the serine C-palmitoyltransferase Lace, Blistery (Drosophila Tensin), and Decapentaplegic and Wingless. It is not clear how these factors signal to JNK or whether they act in a single pathway, let alone whether any of them interact with nonmuscle myosin. It is likely that there are several independent ways of activating JNK, and it has been suggested that induction of apoptosis through JNK activation is a regulatory mechanism to eliminate abnormally developing cells in wing imaginal discs. (2)This leads directly to the second question: are the results of nonmuscle myosin signaling to JNK significant in a developmental context? The fact that bsk1 suppresses the semilethality of flw6 indicates that the interactions that uncovered are not confined to the main experimental model of ectopic JNK activation in wing imaginal discs. The obvious system for studying possible interactions between nonmuscle myosin and JNK would be dorsal closure, which depends on both the coordinated assembly and the contraction of the actomyosin cytoskeleton and on activation of JNK. So far, there is no evidence that dorsal closure is affected in flw mutant embryos; however, there is a maternal contribution of flw that may conceal embryonic phenotypes. Actomyosin and JNK do not promote dorsal closure completely independently from each other; for example, the expression of many components of the actomyosin cytoskeleton is upregulated in response to JNK. Also, actin and myosin failed to accumulate along the leading edge of the epidermis in the puc mutant background. Both findings would place the actomyosin cytoskeleton downstream of JNK, whereas genetic data place flw and zip upstream of JNK and puc. It is possible, however, that actomyosin acts both upstream and downstream of JNK during dorsal closure. Because of the conserved nature of the components involved, it is likely that the finding that nonmuscle myosin can signal to and activate JNK is relevant to furthering the understanding of processes like dorsal closure and wound healing in Drosophila and humans (Kirchner, 2007).
Two independent approaches to understanding the molecular mechanism of cytokinesis have converged on the gene spaghetti-squash (sqh). A genetic screen for mitotic mutants identified sqh1, a mutation that disrupts cytokinesis, which was then cloned by transposon tagging. Independently, the gene that encodes the regulatory light chain of the biochemically defined nonmuscle myosin (MRLC-C) was also cloned. sqh encodes MRLC-C. In sqh1 mutants, the level of stable light chain transcript is greatly reduced. Reversion by transposon excision or transformation with a wild-type copy of the sqh transcription unit rescues cytokinesis failure and other defects in sqh1. Vertebrate homologs of MRLC-C are phosphorylatable and regulate myosin activity in vitro. These studies provide genetic proof that MRLC-C is required for cytokinesis, suggest a role for the protein in regulating contractile ring function, and establish a genetic system to evaluate its function (Karess, 1991).
The X-linked Drosophila gene spaghetti squash (sqh) encodes the regulatory light chain of nonmuscle myosin II. To assess the requirement for myosin II in oogenesis and early embryogenesis, homozygous germline clones were induced of the hypomorphic mutation sqh1 in otherwise heterozygous mothers. Developing oocytes in such sqh1 germline clones often fail to attain full size due to a defect in 'dumping', the rapid phase of cytoplasmic transport from nurse cells. In contrast to other dumpless mutants described to date, sqh1 egg chambers showed no evidence of ring canal obstruction, and no obvious alteration in the actin network. However the distribution of myosin II is abnormal. It is concluded that the molecular motor responsible for cytoplasmic dumping is supplied largely, if not exclusively, by nurse cell myosin II and that regulation of myosin activity is one means by which cytoplasmic transport may be controlled during oocyte development. The eggs resulting from sqh1 clones, though smaller than normal, begin development but exhibit an early defect in axial migration of cleavage nuclei towards the posterior pole of the embryo, in a similar manner to that seen in early cleavage eggs in which the actin cytoskeleton is disrupted. Thus both nurse cell dumping and axial migration require a maternally supplied myosin II (Wheatley, 1995).
Morphogenesis is characterized by orchestrated changes in the shape and position of individual cells. Many of these movements are thought to be powered by motor proteins. However, in metazoans, it is often difficult to match specific motors with the movements they drive. The nonmuscle myosin II heavy chain (MHC encoded by zipper is required for cell sheet movements in Drosophila embryos. To determine if myosin II is required for other processes, a study was made of the phenotypes of strong and weak larval lethal mutations in spaghetti squash (sqh), which encodes the nonmuscle myosin II regulatory light chain (RLC). sqh mutants can be rescued to adulthood by daily induction of a sqh cDNA transgene driven by the hsp70 promoter. By transiently ceasing induction of the cDNA, RLC is depleated at specific times during development. When RLC is transiently depleted in larvae, the resulting adult phenotypes demonstrate that RLC is required in a stage-specific fashion for proper development of eye and leg imaginal discs. When RLC is depleted in adult females, oogenesis is reversibly disrupted. Without RLC induction, developing egg chambers display a succession of phenotypes that demonstrate roles for myosin II in morphogenesis of the interfollicular stalks (this involves three morphologically and mechanistically distinct types of follicle cell migration) and completion of nurse cell cytoplasm transport (dumping). Finally, in sqh mutant tissues, MHC is abnormally localized in punctate structures that do not contain appreciable amounts of filamentous actin or the myosin tail-binding protein p127. This suggests that sqh mutant phenotypes are chiefly caused by sequestration of myosin into inactive aggregates. These results show that myosin II is responsible for a surprisingly diverse array of cell shape changes throughout development (Edwards, 1996).
The Drosophila spaghetti squash (sqh) gene encodes the regulatory myosin light chain (RMLC) of nonmuscle myosin II. Biochemical analysis of vertebrate nonmuscle and smooth muscle myosin II has established that phosphorylation of certain amino acids of the RMLC greatly increases the actin-dependent myosin ATPase and motor activity of myosin in vitro. The in vivo importance of these sites, which in Drosophila correspond to serine-21 and threonine-20, has been asssessed by creating a series of transgenes in which these specific amino acids are altered. The transgene phenotypes were examined in an otherwise null mutant background during oocyte development in Drosophila females. Germ line cystoblasts entirely lacking a functional sqh gene show severe defects in proliferation and cytokinesis. The ring canals (cytoplasmic bridges linking the oocyte to the nurse cells in the egg chamber) are abnormal, suggesting a role of myosin II in their establishment and/or maintenance. In addition, numerous aggregates of myosin heavy chain accumulate in the sqh null cells. Mutant sqh transgene (sqh-A20, A21), in which both serine-21 and threonine-20 have been replaced by alanines, behaves in most respects identically to the null allele in this system, with the exception that no heavy chain aggregates are found. In contrast, expression of sqh-A21, in which only the primary phosphorylation target serine-21 site is altered, partially restores functionality to germ line myosin II, allowing cystoblast division and oocyte development, albeit with some cytokinesis failure, defects in the rapid cytoplasmic transport from nurse cells to cytoplasm characteristic of late stage oogenesis, and some damaged ring canals. Substituting a glutamate for the serine-21 (mutant sqh-E21) allows oogenesis to be completed with minimal defects, producing eggs that can develop normally to produce fertile adults. Flies expressing sqh-A20, in which only the secondary phosphorylation site is absent, appear to be entirely wild type. Taken together, this genetic evidence argues that phosphorylation at serine-21 is critical to RMLC function in activating myosin II in vivo, but that the function can be partially provided by phosphorylation at threonine-20 (Jordan, 1997).
Drosophila Rho-associated kinase (Rok) works downstream of Fz/Dsh to mediate a branch of the planar polarity pathway involved in ommatidial rotation in the eye and in restricting actin bundle formation to a single site in developing wing cells. The primary output of Rok signaling is regulating the phosphorylation of nonmuscle myosin regulatory light chain, and hence the activity of myosin II. Drosophila myosin VIIA, the homolog of the human Usher Syndrome 1B gene, also functions in conjunction with this newly defined portion of the Fz/Dsh signaling pathway to regulate the actin cytoskeleton (Winter, 2001).
Rok signaling regulates the phosphorylation of nonmuscle myosin regulatory light chain (MRLC), and hence the activity of myosin II. Does the phosphorylation state of MRLC modify the multiple hair phenotype of dishevelled mutants? Use was made of a series of mutant spaghetti squash (sqh) transgenes (sqh codes for the Drosophila MRLC) with point mutations in the primary (Ser-21) and secondary (Thr-20) phosphorylation sites, changing them either to glutamic acid (phosphomimetic), or to nonphosphorylatable alanine.
Can the phosphorylation state of MRLC also modulate Fz/Dsh signaling? An examination was made to determine whether the phosphomimetic and nonphosphorylatable forms of MRLC could directly modify the dsh1 multiple hair phenotype. Introducing one copy of sqhE20E21 reduces the number of multiple hair cells in dsh1 mutants by 5-fold. sqhE21, or sqhA20E21, also suppresses the dsh1 phenotype by more than 2-fold. In contrast, introduction of sqhA21 into the dsh1 background enhances the multiple hair phenotype. The involvement of MRLC in the Fz/Dsh pathway was also examined using the Fz-overexpression assay. Reducing the wild-type sqh gene dosage from two to one, by introducing a single copy of the sqhAX3 null allele, results in a 2-fold suppression of the multiple hair phenotype caused by Fz overexpression. These results support the notion that MRLC functions in the PCP pathway to restrict F-actin bundle assembly to a single site (Winter, 2001).
MRLC phosphorylation in response to Rok activation would be predicted to modify the conformation and elevate the catalytic activity of its associated heavy chain, Zipper (Zip). Does Zip also participate in regulating actin distribution/wing hair number in response to Fz/Dsh? Loss of one copy of the zip gene enhances the dsh1 phenotype by 4.5-fold, consistent with the genetic interaction data between fz/dsh and sqh. These results suggest that myosin II functions positively downstream of Fz/Dsh in regulating actin prehair development (Winter, 2001).
The localization of Zip protein in wing cells further supports its role downstream of Fz/Dsh. At the apical surface of the pupal wing cell, Zip is asymmetrically localized to the distal portion of the cell, where prehair growth initiates. This distal localization appears to coincide, temporally, with prehair initiation. To test whether Zip localization could be modified by Fz/Dsh signaling, Zip distribution at the apical surface was examined in dsh1 mutants. Instead of being concentrated in the distal region of the cell, Zip is concentrated in the center of the cell, where prehairs form in dsh1 mutants (Winter, 2001).
Does reduction in myosin II/Zip activity also result in the multihair phenotype? Use was made of the hypomorphic zip02957, since zip and sqh null mutations appear to be cell lethal in the wing. As is the case with rok, some homozygous zip02957 wing cells possess multiple F-actin prehairs (Winter, 2001).
Tests were performed to see if the gene crinkled (ck) is involved in the Fz/Dsh signaling pathway regulating wing hair number because (1) ck mutant cells in the wing lead to multiple hair and split hair phenotypes, and (2) ck encodes the Drosophila myosin VIIA protein. Mutations in mouse myosinVIIA lead to stereocilia disorganization and the formation of multiple bundles of stereocilia (Winter, 2001 and references therein).
Reduction of ck activity potently suppresses the dsh1 multiple hair phenotype. This result contrasts with the result that zip1 enhances the dsh1 multiple hair phenotype, and suggests that the two myosin heavy chains have opposing effects in regulating prehair assembly (Winter, 2001).
Both myosin heavy chain genes were tested for their ability to interact with the hs-fz induced multiple hair phenotype, and again it was found that they have opposing effects. Surprisingly, loss of one copy of zip slightly but significantly enhances the late hs-fz multiple hair phenotype, while loss of one copy of ck markedly suppresses this phenotype. These results are the reverse of what one would expect based on their interactions with dsh1, and suggests the possibility that there is a signal from Fz to Ck that is independent of Dsh, or that the multiple hair phenotypes resulting from hypo- or hyper-activity of the Fz/Dsh pathway arise via distinct biochemical mechanisms (Winter, 2001).
To further assess the nature of the relationship between the two myosins, the effect of raising or lowering the activity of MRLC on the ck phenotype was tested. The multiple hair phenotype in animals homozygous for a weak ck mutation is enhanced by one copy of the sqhE20E21 transgene (and hence, a probable increase in myosin II activity), but not by a sqhA20A21 transgene. Taken together, these experiments suggest that a balance between the activities of myosin II and myosin VIIA is important in regulating wing hair number (Winter, 2001).
Unlike other characterized PCP mutants that affect both orientation and number of wing hairs, the primary defect in Drok2 clones appears to be the presence of multiple hairs per cell, with little or no wing hair orientation defect. This suggested that Rok and what lies downstream are involved in transmitting a subset of the Fz/Dsh signal. Supporting this idea, it was found that tubP-Drok and sqhE20E21 suppress the multiple hair phenotype of dsh1, but not the hair misorientation phenotype. Additional data supporting this conclusion comes from observing the site of prehair initiation. Prehairs emerge aberrantly from the center of dsh1 mutant cells, rather than from the distal vertex as seen in wild type cells. Such mispositioning of prehair initiation correlates with the failure to acquire the proper distal orientation. While tubP-Drok expression suppresses multiple prehair formation, it does not affect the site of F-actin initiation in dsh1. Finally, the hair orientation defect resulting from Fz overexpression (via hs-fz) at 24 hours is suppressed by reducing dsh gene dosage but not that of RhoA, rok, sqh or ck. Taken together, these observations suggest that separate mechanisms allow Fz/Dsh to independently regulate the number and the orientation of prehairs, and that only the former involves Rok signaling (Winter, 2001).
The data presented in this study suggest that the Rok/myosin II pathway is involved in regulating the number -- but not orientation -- of the wing hair. What then are the components that regulate wing hair orientation? One possibility is that a bifurcation of the pathway occurs at the level of RhoA, with a separate effector pathway regulating wing hair orientation. In the eye, the JNK pathway has been implicated in functioning downstream of RhoA in regulating ommatidial polarity. However, the function of the JNK pathway in the wing has not been described, and a signaling pathway that regulates transcription is unlikely to encode the requisite spatial information necessary for selection of the site of prehair initiation. Therefore, it is likely that a separate signal from or upstream of RhoA may control the selection of the F-actin assembly site, and therefore the orientation of the wing hair (Winter, 2001 and references therein).
By what mechanism do myosins restrict F-actin bundle formation? In light of the finding that myosin II is concentrated at the site of prehair formation, it seems plausible that myosin II is actively involved in either the recruitment of F-actin to the prehair site, or that it directly participates in the assembly of actin bundles, or both. Studies of mammalian myosin II provide a precedent for a role in the formation of F-actin bundles. Phosphorylation of MRLC promotes a conformational change in myosin II from a folded to an extended state that readily forms multivalent bipolar filaments capable of binding multiple actin filaments. This is thought to result in F-actin bundling and stress fiber formation (Winter, 2001 and references therein).
It appears that in the developing wing, the level of MRLC phosphorylation/myosin II activity must be within an optimal range to establish the formation of a single hair. It is possible that the efficiency of F-actin bundle formation is regulated by MRLC phosphorylation in a manner similar to the control of stress fiber formation. If one further assumes that there are certain bundling substrates present only at limiting concentrations (e.g., F-actin itself), then one would predict that the assembly of one F-actin bundle would reduce the probability of forming a second bundle. When MRLC phosphorylation falls below some threshold level (e.g., in rok mutant cells), the efficiency of primary bundle formation is reduced, and thus the concentration of the limiting substrate remains at sufficient levels to support the assembly of secondary bundles/prehairs. Conversely, if MRLC is hyperphosphorylated (e.g., in Fz-overexpressing cells), the bundling efficiency may increase such that the threshold concentration for bundle formation would be reduced, thereby increasing the probability of assembling multiple bundles/prehairs. Future studies will be required to determine the detailed mechanisms involved (Winter, 2001).
In addition to nonmuscle myosin II, which resembles the myosin II from skeletal muscle, there exists a large class of unconventional myosins that have different properties and potential functions in nonmuscle cells. For instance, several different classes of unconventional myosins are expressed in inner ear epithelium with different subcellular localization. Mutations in three of the unconventional myosins, myosin VI, VIIA, and XV, cause hearing/balancing defects in mice, two of which when mutated in humans result in deafness. Of particular interest in the context of this study is myosin VIIA, mutations of which are responsible for mouse shaker-1 and human Usher's syndrome 1B. Loss-of-function ck (Drosophila Myosin VIIA) mutants exhibit a multiple hair and split wing hair phenotype. ck exhibits strong genetic interactions with components of the signal transduction pathway defined in this study, and has the opposite effects as that of myosin II. The seemingly antagonistic relationship between myosin II and myosinVIIA may suggest a mechanism in which the balance of the activities or stoichiometry of these two myosins is critical for the common process they regulate. For example, myosin II and myosin VIIA may share some common, limiting component(s) required for their activity. Thus, by reducing the myosin VIIA dose, myosin II has a larger share of the common component(s) and thus its activity is upregulated (Winter, 2001 and references therein).
Mechanisms that regulate axon branch stability are largely unknown. Genome-wide analyses of Rho GTPase activating protein (RhoGAP) function in Drosophila using RNA interference has identified p190 RhoGAP as essential for axon stability in mushroom body neurons, the olfactory learning and memory center. RhoGAP inactivation leads to axon branch retraction, a phenotype mimicked by activation of GTPase RhoA and its effector kinase Drok and modulated by the level and phosphorylation of myosin regulatory light chain. Thus, there exists a retraction pathway from RhoA to myosin in maturing neurons, which is normally repressed by RhoGAP. Local regulation of RhoGAP could control the structural plasticity of neurons. Indeed, genetic evidence supports negative regulation of RhoGAP by integrin and Src, both implicated in neural plasticity (Billuart, 2001).
Biochemical and genetic evidence indicates that a key output for Drok signaling in vivo is the regulation of phosphorylation of myosin regulatory light chain (MRLC) encoded by spaghetti squash (sqh). To test if endogenous MRLC is part of the axon retraction pathway regulated by p190, genetic interaction experiments were performed by reducing the dose of endogenous sqh in the context of the p190 dsRNA expression. Marked suppression of the phenotype was observed in flies heterozygous for a null mutation of sqh (sqhAX3). In contrast, expression of a phosphomimetic mutant, Sqh-E20E21, markedly enhanced the p190 phenotype, whereas analogous expression of a nonphosphorylable form (Sqh-A21) had no effect. Further, truncation of the medial lobe was frequently observed when Sqh-E20E21 was expressed with the intermediate p190 RNAi line. This is evident from the FasII staining, showing that the medial ß axons (strongly FasII positive) only extend a fraction of the length of the medial lobe. This phenotype was only observed in the strongest p190 RNAi lines, never in the intermediate line alone. Taken together, these results strongly suggest that Drok and phosphorylation of Drosophila MRLC participate in mediating axon retraction as a result of p190 inactivation (Billuart, 2001).
Drosophila Myosin-binding substrate
(MBS), the homolog of mammalian MBS, was identified to study the roles of myosin phosphatase in morphogenesis. Myosin phosphatase negatively regulates nonmuscle myosin II through dephosphorylation of the myosin regulatory light chain (MRLC: Spaghetti squash). Myosin phosphatase's regulatory myosin-binding subunit, MBS, is responsible for regulating the myosin phosphatase catalytic subunit in response to upstream signals and for determining myosin phosphatase's substrate specificity (Mizuno, 2002).
Embryos defective for both maternal and zygotic MBS demonstrate a failure in dorsal closure. In the mutant embryos, the defects are mainly confined to the leading edge cells which fail to fully elongate. Ectopic accumulation of phosphorylated MRLC is detected in the lateral region of the leading edge cells, suggesting that the role of MBS is to repress the activation of nonmuscle myosin II at the subcellular location for coordinated cell shape change. Aberrant accumulation of F-actin within the leading edge cells may correspond to the morphological aberrations of such cells. Similar defects were seen in embryos overexpressing Rho-associated kinase, suggesting that myosin phosphatase and Rho-kinase function antagonistically. The genetic interaction of MBS with mutations in the components of the Rho signaling cascade also indicates that MBS functions antagonistically to the Rho signal transduction pathway. The results indicate an important role for myosin phosphatase in morphogenesis (Mizuno, 2002).
To examine whether defects in the dorsal closure in the embryos lacking MBS or overexpressing wild-type Rho kinase are due to an aberrant activation of nonmuscle myosin II, the genetic interactions with zipper (zip), which encodes the heavy chain of nonmuscle myosin II, were analyzed. About 25% of the progeny from crossing the females transheterozygous with DMBSP2 and Df(3L)th117 to the males heterozygous for DMBSE1 are embryonically lethal. It was expected that a reduction in the gene dosage of zip+ would suppress the defects in the MBS mutant or Rho-kinase-expressing embryos. When DMBSP2/Df(3L)th117 females are mated with males heterozygous for both DMBSE1 and zipEbr, half of the embryos defective for both maternal and zygotic MBS should be heterozygous for zipEbr. As expected, the embryonic lethality was reduced to nearly half that of the corresponding cross. Similarly, the heterozygosity for zipEbr considerably suppresses lethality due to ectopic wild-type Rho kinase expression. These results strongly suggest that either loss of MBS+ or overexpression of wild-type Rho-kinase causes hyperactivation of nonmuscle myosin II through increasing the levels of phosphorylation of MRLC (Mizuno, 2002).
zipEbr is a point mutation reported to be highly sensitive to genetic backgrounds. About 70% of the flies transheterozygous between zipEbr and zip02957 have malformed wings with varying degrees of severity. Although zipEbr is recessive, a considerable percentage of the flies heterozygous for both zipEbr and the mutations in the components of the Rho signaling pathway such as DRho1 and DRhoGEF2 produced similar defects. A half reduction of Drok, which encodes Rho-kinase, also dominantly enhances zipEbr. This indicates the involvement of the Rho signaling pathway and its effector, Rho-kinase, in the myosin function of adult wing morphogenesis. When the flies are also heterozygous for DMBSE1, wing malformation is significantly suppressed, suggesting that MBS functions antagonistically to the Rho signaling pathway (Mizuno, 2002).
Myosins are a superfamily of actin-dependent molecular motor proteins, among which the bipolar filament forming myosin II has been the most studied. The activity of smooth muscle/non-muscle myosin II is regulated by phosphorylation of the regulatory light chains, which in turn are modulated by the antagonistic activity of myosin light chain kinase and myosin light chain phosphatase. The phosphatase activity is mainly regulated through phosphorylation of its myosin binding subunit Mypt [FlyBase term: Myosin binding subunit (Mbs)]. To identify the function of these phosphorylation events, the Drosophila homolog of MYPT has been molecularly characterized, and its mutant phenotypes have been analyzed. Drosophila MYPT is required for cell sheet movement during dorsal closure, morphogenesis of the eye, and ring canal growth during oogenesis. These results indicate that the regulation of the phosphorylation of myosin regulatory light chains, or dynamic activation and inactivation of myosin II, is essential for its various functions during many developmental processes (Tan, 2003).
Myosins involved in a variety of essential processes that include muscular
contraction, cytokinesis, vesicle transport, cell movement and cell shape
change. Among the 17 subclasses of myosins, conventional myosins,
known as myosin IIs, have been the most studied. Myosin IIs form bipolar
filaments that drive contractile events by bringing together actin filaments
of opposite polarity. Myosin II molecules are hexameric enzymes consisting of
two heavy chains, two regulatory light chains (MRLCs - coded for by spaghetti squash in Drosophila), and two essential light
chains. They can be subclassified into four groups based on their motor domain
(or tail) sequences: (1) sarcomeric myosins, (2) vertebrate smooth muscle/non-muscle
myosins, (3) Dictyostelium/Acanthamoeba type myosins and (4) yeast type
myosins (Tan, 2003 and references therein).
The activity of smooth muscle/non-muscle myosin II is regulated by the
phosphorylation of MRLC that is modulated by the antagonistic activity of
myosin light chain kinase (MLCK) and myosin light chain phosphatase (MLCP).
MLCP is composed of three subunits: a catalytic subunit made up of protein
phosphatase 1c ß (also called delta); a myosin binding or targeting
subunit (MYPT), and a small subunit of unknown function. MYPT binds and
confers the selectivity of PP1c for myosin (Tan, 2003 and references therein).
The phosphatase activity of MLCP can be regulated in several ways (reviewed
by Hartshorne, 1998; Somlyo, 2000). Rho-kinase (ROCK) phosphorylates an inhibitory phosphorylation site on MYPT and inhibits the phosphatase activity in smooth muscle. This phosphorylation may occur through ZIPK (leucine zipper interacting protein kinase)-like kinase or
integrin-linked kinase. Myotonic dystrophy protein kinase phosphorylates the same
inhibitory phosphorylation site, although it is not clear whether this
phosphorylation event also goes through ZIPK. In addition, protein kinase C
(PKC) can phosphorylate the ankyrin repeat region of MYPT, and thus attenuate
the interaction of MYPT with PP1c and MRLC.
Furthermore, CPI-17, a smooth muscle-specific inhibitor of MLCP, can also
regulate the phosphatase activity of MLCP. Phosphorylation of CPI-17 by PKC,
or ROCK, or protein kinase N, or p21-activated kinase (PAK) dramatically
enhances the inhibition ability of CPI-17.
Finally, MRLC can also be phosphorylated by ROCK and PAK, which itself is a
substrate of Rac and Cdc42. Thus ROCK can regulate MRLC phosphorylation both
through direct phosphorylation of MRLC and through inactivation of MLCP.
Importantly, although the biochemistry of these phosphorylation events is well
characterized, the physiological significance of these regulatory steps in
vivo remains to be explored (Tan, 2003).
The in vivo function of non-muscle myosin II has been extensively analyzed
in Drosophila melanogaster, Dictyostelium discoideum and
Saccharomyces cerevisiae . Drosophila has a single non-muscle myosin
II heavy chain encoded by zipper (zip), as well as a single
non-muscle myosin II regulatory light chain encoded by spaghetti squash
(sqh). Analysis of the phenotypes associated with mutations in
zip and sqh have revealed that non-muscle myosin II
regulates cell shape changes and cell movements in multiple processes such as
cytokinesis, dorsal closure and oogenesis. In
addition, mutations in both zip and sqh affect planar cell
polarity during development (Tan, 2003).
The temporal requirement of zip has been studied in
sqh2 mutant animals that carry a sqh transgene
driven by a heat shock promoter. This analysis showed that sqh
activity is needed for eye and leg imaginal discs morphogenesis. Also, during
oogenesis, sqh is required for morphogenesis of interfollicular
stalks, border cell migration, centripetal cell ingression, dorsal appendage
cell migration, and rapid transport of the nurse cell cytoplasm into the
oocyte. Inhibition of this transport was also observed in animals that carry
homozygous sqh1 germline clones (GLCs) (Tan, 2003 and references therein).
The in vivo function of MRLC phosphorylation was determined by expression
of sqh transgenes that contain mutated phosphorylation sites in a
sqh null mutant background.
Embryos carrying the null mutation sqhAX3 die, mostly
during the first larval instar, and sqhAX3 GLCs develop
extensive defects, including failure in cytokinesis, during oogenesis.
SqhA20A21, in which both the primary and secondary phosphorylation sites have been
changed to alanine, fails to rescue sqhAX3, indicating
that phosphorylation of Sqh is important for myosin II function. In support of
this, a change of serine 21 to glutamic acid (SqhE21), that presumably mimics
constitutive phosphorylation of Sqh, substantially rescues the
sqhAX3 oogenesis phenotype (Tan, 2003).
To gain further insight into the regulation of Zip and to define precisely
the in vivo function of MLCP, the Drosophila homolog
of the MYPT gene (DMYPT) has been cloned. DMYPT is essential
for cell sheet movement during dorsal closure, morphogenesis during eye
development, and ring canal growth during oogenesis. These results indicate that
regulation of the phosphorylation state of MRLC, and dynamic activation and
inactivation of myosin II, are essential for its various functions during many
developmental processes (Tan, 2003).
A BLAST search of the Drosophila database with mammalian MYPT sequences reveals that the Drosophila genome has a single related gene, CG5891. CG5891 is predicted to encode a protein with limited homology to mammalian MYPT at the N terminus. However, sequence analysis of several cDNAs derived from CG5891
uncovered additional regions of homology between
the mammalian and fly homologs, suggesting that the predicted CG5891
gene was incorrectly annotated. A representative cDNA, AT12677, encodes an ORF
of 1101 amino acids (aa) that has been named Drosophila MYPT (DMYPT) to
follow the nomenclature of the mammalian protein. A comparison of the compiled
DMYPT cDNA and genome sequences shows that the DMYPT locus
contains 18 exons and 17 introns. The start codon lies in the second exon and the stop codon in
the last. Sequence alignment shows that DMYPT shares significant homology with
human MYPTs in three regions: the N terminus containing several ankyrin repeats, the C
terminus, and a short peptide in the middle that contains the highly conserved
inhibitory phosphorylation site (Tan, 2003).
To characterize the consequences of loss of DMYPT function during
development, mutations in the DMYPT gene were sought. Two
P-element transposon insertions in the DMYPT locus have been defined
molecularly by recovery of flanking genomic sequence. EP(3)3727,
in the first intron, is homozygous viable and l(3)03802, in the tenth
intron, is associated with zygotic lethality. Several
deficiencies were identified that remove DMYPT sequences based on genetically defined breakpoints as well as their failure to complement l(3)03802. Df(3L)th102
deletes DMYPT entirely and thus serves as a complete loss-of-function
allele for use in this study (Tan, 2003).
To determine whether the l(3)03802 P-element insertion within the
DMYPT locus is responsible for the lethality, and to generate new
deletion alleles, both DMYPT P-element insertions were excized using
the Delta2-3 transposase. Mobilization of each element resulted in the
recovery of both viable precise excisions and lethal imprecise excisions.
Among the >200 excisions derived from l(3)03802, over half were
viable, indicating that the lethality associated with the l(3)03802
chromosome is due to disruption of DMYPT and not another lethal hit.
Thus l(3)03802 is renamed as DMYPT03802 and
EP(3)3727 as DMYPT3727. Two of the strongest
embryonic lethal excision lines, DMYPT2-188 and
DMYPT2-199, like the original insert,
DMYPT03802, fail to complement Df(3L)th102 and
are described in detail below. Eleven of the 39 lethal excisions derived from
DMYPT3727 failed to complement with
DMYPT03802 and Df(3L)th102: this is consistent
with the notion that they disrupt DMYPT activity (Tan, 2003).
To confirm that the DMYPT03802 insertion disrupts DMYPT
function and that the cDNA derived from the DMYPT locus encodes all
the functions associated with DMYPT activity, the original lethal P
insertion was rescued with a transgene containing a heat shock promoter driving a
DMYPT cDNA. Following 1-hour heat treatments daily from embryogenesis
to eclosion, hs-DMYPT fully rescues DMYPT03802
homozygous animals to adulthood. Stopping heat treatment 1 to 2 days before
eclosion led to incomplete rescue of DMYPT03802, with
adults developing wing and leg defects similar to those noted for zip
or sqh mutants partially rescued by a transgene. Stopping heat treatment 3 days prior to eclosion resulted in no rescue
to adulthood. The complete rescue of the lethality associated with
DMYPT03802 by the hs-DMYPT transgene demonstrates
that loss of DMYPT activity is responsible for the lethal
phenotype (Tan, 2003).
To assess the timing and cause of lethality associated with the
DMYPT03802 insertion, embryos were collected and analyzed.
Lethal phase analysis showed that 44% of homozygous
DMYPT03802 animals died during embryogenesis, while the
remaining 56% died during early first larval instar (485 total embryos
counted). More than 80% of the dead mutant embryos displayed a failure of
dorsal closure with a characteristic dorsal hole in their cuticles. The size of the
hole in such flies is variable and is also influenced by the genetic
background. Homozygous Df(3L)th102 embryos, as well as
DMYPT03802/Df(3L)th102 embryos also showed dorsal
closure defects. The embryonic cuticle phenotype of
DMYPT03802/Df(3L)th102 is more severe (more embryos
displayed large dorsal holes) than homozygous DMYPT03802,
suggesting that DMYPT03802 is a hypomorphic allele. In
addition, all of the embryonic lethal excision lines analyzed that were
derived from DMYPT03802, and ten of the
lethal excision lines from DMYPT3727, produced embryos
with dorsal closure defects. Altogether, these results indicate that
DMYPT is required for dorsal closure (Tan, 2003).
Dorsal closure involves a cell sheet movement where the dorsal-lateral
ectoderm on both sides of the developing embryo moves toward the dorsal
midline to cover a degenerative squamous epithelium, the amnioserosa.
This epithelial cell sheet movement encloses the embryo in a continuous
protective epidermis. Genetic loss-of-function studies have identified the Jun
N-terminal kinase (JNK) signal transduction cascade as one of the key
modulators of dorsal closure morphogenesis.
Transcriptional targets of JNK signaling include decapentaplegic
(dpp), a secreted morphogen related to the bone morphogenetic
proteins (BMPs), and puckered (puc), a dual-specificity
phosphatase that mediates a negative feedback loop of the JNK signal
transduction pathway via dephosphorylation of JNK (Tan, 2003).
To determine whether the failure of dorsal closure in DMYPT
mutants is due to an influence on JNK signaling, dpp
expression was assayed in the leading cells of the ectoderm during closure. In situ
hybridization revealed that the spatial and temporal expression pattern of
dpp is normal in DMYPT mutant embryos, suggesting that DMYPT does not function through the JNK pathway during dorsal closure (Tan, 2003).
To further examine the cause of dorsal closure defects in the mutants, DMYPT mutant embryos were stained for markers that allowed analysis of
cell polarity and shape in the dorsal ectoderm. Apically
localized phosphotyrosine immunoreactivity similar to wild-type flies was observed. Moreover, there was normal basolateral fasciclin III immunostaining. Altogether, these
results suggest that there are no gross defects in cell orientation or
polarity. However, it was noticed that older mutant embryos begin to show
abnormal cell shapes at the leading edge of the epidermis, which could account
for the defects in dorsal closure observed in the DMYPT mutants (Tan, 2003).
Consistent with the late embryonic defects observed in DMYPT
zygotic mutants, it was found that DMYPT is maternally contributed and
ubiquitously expressed during embryogenesis. This maternal
supply of DMYPT is likely the reason that the dorsal closure phenotype is
variable among embryos and is influenced by genetic background. However, this question cannot be addressed directly since DMYPT is required during
oogenesis (Tan, 2003).
During oogenesis, each cystoblast divides four times with incomplete
cytokinesis and produces one oocyte and fifteen support nurse cells that are
all connected through cleavage furrows. These cleavage furrows subsequently
develop into ring canals. These open rings allow the nurse cells to transport
cytoplasm into the oocyte, slowly from stage 6 to stage 10, then rapidly at
stage 11. This fast phase of transport is referred to as 'dumping', and has
been shown to require the activity of Sqh (MRLC). In sqh mutant germline egg chambers, dumping is blocked (Tan, 2003).
To analyze the role of DMYPT during oogenesis, homozygous mutant germline clones (GLCs) were generated of DMYPT03802
using the FLP-FRT/dominant female sterile technique.
Females carrying DMYPT03802 homozygous GLCs lay few tiny
eggs, about a quarter of the size of wild type eggs, that do not develop. Examination of the mutant egg chambers revealed that the
dumping of nurse cell cytoplasm to the oocyte is blocked. This
is similar to the dumpless phenotype observed with sqh homozygous
mutant GLCs as well as for mutants in other actin binding proteins (Tan, 2003).
To investigate the basis of the dumpless phenotype associated with
DMYPT03802 GLCs, actin filaments were stained using Texas
Red phalloidin. The most obvious defect involves the ring canals. At stage 8,
wild-type egg chambers have large bagel-shaped ring canals. In contrast, the ring canals of DMYPT03802 GLC egg chambers are very small (Tan, 2003).
To determine whether the ring canals of DMYPT03802 GLCs
never enlarge, or whether they grow and then collapse, the ring
canals were examined in different stage egg chambers. In wild-type egg chambers, ring canals grow from 1 µm at stage 2 to 10 µm at stage 11. In
contrast, the ring canals of DMYPT03802 GLCs barely grow. Mutation of
DMYPT in follicular cells have no effects on the ring canal growth, suggesting that DMYPT is required in the germline for ring canal growth. Presumably, these small ring canals cannot support the fast phase cytoplasmic transport and thus cause the dumpless phenotype resulting in tiny eggs (Tan, 2003).
In addition to actin, several other proteins, including Hu-li tai shao
(Hts), Kelch, and phosphotyrosine (pY)-containing proteins, are recruited to ring canals as they form. Immunolocalization experiments have revealed that both Hts and Kelch are localized to the small DMYPT mutant ring
canals. Interestingly, although pY staining is present in the mutant ring canals, an ectopic accumulation of pY staining was also observed in the nurse cells. The basis of
this ectopic accumulation remains to be determined (Tan, 2003).
Next, the subcellular distribution of Zipper was examined. Mutation of Sqh causes Zip to form aggregates, thus an effect on Zip distribution in the absence of DMYPT was expected.
Surprisingly, no major changes in Zip distribution were detectable between
wild-type egg chambers and DMYPT GLCs. In both cases, Zip was
uniformly distributed at low level with enhanced cell cortex localization. These observations are consistent with the result that DMYPT mutations have no effect on Zip localization during dorsal closure (Tan, 2003).
Previous studies have shown that the Rho family GTPases, Rac1, RhoA, and
Cdc42, each play a role in dorsal closure, and may
influence myosin activity through a RhoA mediated signal. Programmed
overexpression of these genes by the eye-specific GMR promoter causes distinct
rough eye phenotypes. To pinpoint the relationship of DMYPT with these
GTPases, the effects of reducing DMYPT activity on the
rough eye phenotypes was examined. Interestingly, reduction of DMYPT strongly
enhances the eye phenotype caused by GMR-Rac7A. The
eyes of GMR-Rac7A/DMYPT03802 flies are much
smaller, with fewer bristles and hexagonal-shaped ommatidia, than those of
GMR-Rac7A/OreR flies. Consistent with the idea that the
P-insertion and the excisions are hypomorphic alleles, Df(3L)th102
enhances the GMR-Rac7A eye phenotype to an even greater
extent than either DMYPT03802, DMYPT2-188 or
DMYPT2-199. However, reduction of
DMYPT has no effect on the size of the rough eye caused by either
GMR-RhoA or GMR-Cdc42, although it does enhance the rough eye
phenotype caused by GMR-RhoA since fewer bristles form.
Together, these data suggest that DMYPT plays a role in eye development and functions downstream of, or in parallel with Rac and Rho (Tan, 2003).
RhoA functions downstream of Rac in determining ommatidia polarity in the
eyes. Reducing the dosage of RhoA enhances the effect of
sev-RacN17, a dominant negative form of Rac driven by the
sevenless (sev) enhancer-promoter in the eye, and suppresses
the activity of sev-RacV12, which encodes a constitutively
active form of Rac. Consistently, overexpression of RhoA
(sev-RhoA) rescues sev-RacN17, while reduction in
the amount of Rac using a deficiency that uncovers Rac has
no effect on the gain-of-function RhoA phenotype. Thus, similar to
the Rho dependence on Rac function observed in mammalian fibroblasts, some
developmental events in Drosophila also rely on a hierarchy of GTPase
function (Tan, 2003).
Consistent with these observations, reducing the dosage of RhoA
partially suppresses the rough eye phenotype caused by GMR-Rac. In
fact, mutations of all the putative positive regulators of myosin activity
(RhoA-Zip signaling pathway), including RhoA, Drok and zip
itself, moderately suppress the rough eye phenotype of GMR-Rac,
opposing the effect of DMYPT mutants. This suggests that the RhoA-Zip signaling pathway functions
downstream of Rac, and that DMYPT is a negative regulator of the
pathway (Tan, 2003).
Importantly, replacing the phosphorylation sites of Sqh with alanine
remarkably suppresses the rough eye phenotype, while replacing them with
glutamic acid to mimic phosphorylation slightly enhances the phenotype. This suggests that dephosphorylation of Sqh is important in eye morphogenesis
and that DMYPT may be involved in regulating the dephosphorylation of myosin
light chain in eye development (Tan, 2003).
To examine whether other myosins are also involved in this process, the effect of myosin VIIA, an unconventional myosin encoded by
crinkled (ck), was included in the same assay. Myosin VIIA was chosen
because ck and zip behave antagonistically in wing hair
number determination in the Drosophila adult wing.
Interestingly, ck behaves just the opposite of myosin II (Zip) during eye
morphogenesis, since a reduction in ck activity enhances the
GMR-Rac rough eye phenotype, nearly to the same extent as a reduction
in DMYPT (Tan, 2003).
The regulation of MRLC phosphorylation is essential to modulate myosin II
activity and can be controled by several distinct mechanisms. For instance,
RhoA can activate its effector ROCK that in turn phosphorylates MYPT, either
directly or indirectly. MYPT phosphorylation inhibits the phosphatase activity
of MLCP and leads to elevation of MRLC phosphorylation. Phosphorylation of
MRLC can also be increased by activation of MLCK, another downstream target of
RhoA. Thus, the antagonistic activity of kinase and phosphatase
is thought to engender a delicate balance of myosin II activity modulated
through the phosphorylation state of its regulatory light chain (Tan, 2003).
To assess the relationship between DMYPT regulation of myosin II and
signaling via the Rho GTPase family members, the
Drosophila eye was examined since sensitive genetic interactions can be observed. RhoA function downstream of, or in parallel
with, Rac has been implicated in regulation of orientation of ommatidia in the eye. Consistent with this, reducing the amount of RhoA, Drok
and zip partially alleviates the eye defect associated with
overexpression of Rac, while reducing the dosage of a putative negative
regulator of myosin enhances the rough eye phenotype. Furthermore, expression
of a non-phosphorylatable form of Sqh, which presumably reduces the
activity of Zip, dramatically rescues the phenotype, while overexpression of a
phospho-mimicking Sqh mutant, which should increase the activity of myosin,
exacerbates the eye defects. Taken together, these data indicate that the
regulation of myosin II activity via balancing the phosphorylation level of
Sqh is critical for proper morphogenesis of the Drosophila eye. Based
on these results, it is proposed that it is DMYPT that mediates myosin II
downregulation in this system (Tan, 2003).
Interestingly, crinkled (myosin VIIA), an unconventional myosin,
behaves antagonistically to Zip/myosin II in both eye morphogenesis and wing hair number restriction. This
suggests that various myosins interact in different cell types to regulate
reorganization of the actin cytoskeleton. It will be interesting to determine
the specificity of functions of different myosins and their modes of
regulation. Since there are many different myosins but only a single MYPT in
Drosophila, it remains to be determined whether, and how, DMYPT
interacts with other myosins (Tan, 2003).
In conclusion, the Drosophila homolog of
mammalian MYPT, accordingly named DMYPT, has been identified. DMYPT
plays multiple roles during Drosophila development. Loss of
DMYPT function leads to blockage of rapid transport of nurse cell
cytoplasm, inhibition of ring canal growth, failure of dorsal closure, defects
of eye morphogenesis, and other unidentified processes during pupae
development. Furthermore, the data indicate that dynamic regulation of myosin
II activity via regulating phosphorylation level of myosin regulatory light
chain by DMYPT is critical for the function of myosin II (Tan, 2003).
Neuronal cells must extend a motile growth cone while maintaining the cell body in its original position. In migrating cells, myosin contraction provides the driving force that pulls the rear of the cell toward the leading edge. The function of myosin light chain phosphatase, which down-regulates myosin activity, has been characterized in Drosophila photoreceptor neurons. Mutations in the gene encoding the myosin binding subunit of this enzyme cause photoreceptors to drop out of the eye disc epithelium and move toward and through the optic stalk. This phenotype is due to excessive phosphorylation of the myosin regulatory light chain Spaghetti squash rather than another potential substrate, Moesin, and the phenotype requires the nonmuscle myosin II heavy chain Zipper. Myosin binding subunit mutant cells continue to express apical epithelial markers and do not undergo ectopic apical constriction. In addition, mutant cells in the wing disc remain within the epithelium and differentiate abnormal wing hairs. It is suggested that excessive myosin activity in photoreceptor neurons may pull the cell bodies toward the growth cones in a process resembling normal cell migration (Lee, 2004).
Nonmuscle myosin II consists of a hexamer of two myosin heavy chains (MHC), two myosin light chains (MLC), and two myosin regulatory light chains (MRLC). Phosphorylation of key serine and threonine residues on MRLC stimulates the ATPase activity of MHC and promotes its assembly into filaments, leading to stress fiber contraction. Mutations in the Drosophila orthologs of these myosin subunits have provided insight into the developmental functions of myosin II. Mutations in zipper (zip), which encodes MHC, cause defects in cytokinesis, closure of the dorsal embryonic epidermis over the amnioserosa, axon patterning, and myofibril formation. spaghetti squash (sqh), encoding MRLC, is required for cytokinesis, oogenesis, and imaginal disc eversion (Lee, 2004 and references therein).
Actin-binding proteins of the ezrin, radixin, and moesin (ERM) family are thought to link transmembrane proteins to the actin cytoskeleton. ERM proteins are activated by phosphorylation of a conserved threonine residue, which inhibits association between the N-terminal FERM domain and C-terminal actin-binding domain of the protein, freeing them to bind to other substrates. Moesin-like (Moe) is the only representative of this family in Drosophila. Moe mutants have abnormal oocyte polarity because defects in the anchorage of actin filaments to the oocyte cortex disrupt the localization of maternal determinants. In addition, Moe mutant cells in the wing disc undergo an epithelial-to-mesenchymal transition and adopt invasive migratory behavior (Lee, 2004 and references therein).
Interestingly, genetic and biochemical studies implicate the same kinase and phosphatase in the regulation of both nonmuscle myosin II and Moesin. Rho-associated kinase (ROCK/Rok) has been shown to phosphorylate MRLC in both mammalian and Drosophila systems. Myosin light chain kinase (MLCK) also can phosphorylate and activate MRLC; MLCK seems to act at the periphery of the cell, whereas ROCK is active in more central regions. Although ERM proteins are positively regulated by Rho GTPases, it is not clear whether they are directly phosphorylated by ROCK or by phosphoinositide-regulated kinases. However, in Drosophila wing disc development Moe seems to act antagonistically to Rho1 and rok (Lee, 2004 and references therein).
A major antagonist of the Rok/myosin signaling pathway is myosin light chain phosphatase (MLCP). This serine/ threonine protein phosphatase is a heterotrimer consisting of a catalytic subunit (PP1cdelta), a 20-kDa protein of unknown function, and the myosin binding subunit (MBS) that targets MLCP to its substrates, which include both MRLC and Moesin. Phosphorylation by Rok of a specific threonine within a conserved motif in MBS has been shown to inhibit MLCP activity; this suggests that Rok can positively activate MRLC and Moesin both by direct phosphorylation of these two substrates and also by inhibition of MBS. Like zip mutants, Drosophila Myosin binding subunit (Mbs) mutants fail to complete dorsal closure, suggesting that this process requires spatially regulated myosin activation. Mbs is also required for the growth of ring canals during oogenesis, and genetic interactions suggest that it opposes the functions in imaginal disc development of zip, Rho1, and rok. Likewise, Caenorhabditis elegans mel-11, which encodes MBS, and let-502, which encodes Rok, have opposite functions in embryonic elongation (Lee, 2004 and references therein).
Photoreceptor differentiation progresses across the Drosophila eye disc from posterior to anterior and is preceded by an epithelial indentation known as the morphogenetic furrow (MF). Cells in the MF undergo a transient contraction along the apical-basal axis and constrict their apical surfaces. After emerging from the MF, some of these cells assemble into ommatidial clusters, differentiate into photoreceptors, and extend axons through the optic stalk into the brain. Mbs mutations have been identified in a screen for genes required for normal photoreceptor differentiation. Findings on the role of Mbs in photoreceptor development suggest that photoreceptor neurons require Mbs to reduce myosin activity and thus prevent their cell bodies from migrating toward their axon terminals (Lee, 2004).
Mbs exerts its effects on eye development by regulating the phosphorylation state of the Sqh MRLC subunit of nonmuscle myosin II. The level of phosphorylated Sqh is greatly increased in Mbs mutant clones in both the eye and wing discs, and nonphosphorylatable or phosphomimetic forms of Sqh strongly modulate the severity of the Mbs phenotype. In addition, the effect of zip dosage on the Mbs phenotype indicates that p-Sqh acts through Zip to control photoreceptor localization. In vivo data show that in the eye disc Mbs is not required to dephosphorylate Moe. If dephosphorylation of Moe by Mbs occurs in vivo, it may be limited to specific tissues or developmental stages (Lee, 2004).
The identity of the kinase antagonized by Mbs in the eye is less clear. Although it has been reported that Rok can phosphorylate Sqh in vitro and that p-Sqh levels are reduced in rok mutant larvae, normal levels of p-Sqh were detected in rok2 eye disc clones. In addition, overexpression of Rok-CAT in the eye disc has no visible effect on photoreceptor differentiation or localization, and does not seem to enhance the Mbs phenotype. Rok may have a more significant effect on Sqh phosphorylation in other tissues; the lethality caused by overexpression of constitutively active Mbs is partially suppressed by coexpression of the catalytic domain of Rok. Myosin seems to be a downstream effector of Rho and Rok in wing and leg development, and the MEL-11 myosin phosphatase antagonizes the LET-502 Rho kinase in C. elegans development, supporting a role for Rok in phosphorylating Sqh in some cell types (Lee, 2004 and references therein).
Another kinase that might phosphorylate Sqh in the eye disc is MLCK. It has been reported that MLCK phosphorylates MRLC at the periphery of fibroblast cells, whereas ROCK acts in the central domain of these cells. Drosophila Stretchin-MLCK is a very large compound gene that produces multiple alternatively spliced transcripts, and no mutations in this gene have been identified, preventing the analysis of its interactions with Mbs. Another possible kinase is p21-activated kinase (PAK), which has been shown to increase the level of phosphorylated MRLC in cultured cells and to phosphorylate MRLC in vitro. Interestingly, overexpression of a myristylated form of PAK in Drosophila photoreceptors causes their cell bodies to detach from the eye disc epithelium and enter the brain, strongly resembling the Mbs mutant phenotype. Pak mutant photoreceptors develop normally except for axon guidance defects, suggesting that Pak is not essential for myosin activation in these cells. However, a second Pak gene, mushroom bodies tiny, is required for late photoreceptor morphogenesis and adherens junction integrity, and a third Pak gene is present in the genome, raising the possibility that these enzymes have redundant functions and complicating any analysis of their interactions with Mbs (Lee, 2004 and references therein).
The excessive myosin activity present in Mbs mutant photoreceptors causes them to adopt a more basal location in the eye disc and sometimes to enter the optic stalk. Several possible mechanisms for this phenotype have been addressed. Myosin can affect the shape of cultured cells by promoting the assembly of stress fibers and focal adhesions, and a transient accumulation of p-Sqh accompanies the apical constriction and apical-basal contraction of cells in the morphogenetic furrow. It was therefore interesting to enquire whether loss of Mbs might induce these cell shape changes in ectopic regions of the eye disc, resulting in mutant cells that formed a constitutive furrow. However, visualization of the apical surface of mutant clones by p-Tyr or phalloidin staining did not reveal any ectopic apical constriction of cells surrounding the photoreceptor clusters, suggesting that myosin phosphorylation is not sufficient to induce the cell shape changes that occur in the morphogenetic furrow. In addition, the integrity of the epithelial surface surrounding the photoreceptor clusters indicates that loss of Mbs specifically affects the localization of photoreceptor cells (Lee, 2004).
Another possibility is that Mbs mutant cells might undergo an epithelial to mesenchymal transition and become migratory. This phenotype has been reported for wing disc cells mutant for Moe, which encodes a potential substrate of Mbs. However, Mbs mutant cells in the wing disc remain within the epithelium and show no change in their apical-basal localization, although p-Sqh is up-regulated to a similar extent in both the wing and eye discs. In addition, Mbs mutant photoreceptors seem to retain some aspects of their epithelial character; they continue to express the epithelial apical junction proteins Patj, Crumbs, and E-cadherin. These proteins are present apical to mislocalized nuclei, suggesting that the entire cell is affected rather than the position of the nucleus within the cell. In contrast, the nuclei of klarsicht or Glued mutant cells are basally located within the cell due to defective dynein function (Lee, 2004).
The model that is favored is that unregulated myosin generates a traction force that pulls photoreceptor cell bodies toward their axon terminals. This would explain why the Mbs phenotype is specific to photoreceptors rather than wing disc cells or undifferentiated cells in the eye disc. It also would explain why the movement of mutant cells is directed toward the optic stalk or, in a disco background, toward the axon terminals within the eye disc. This abnormal force also might be accompanied by changes in adhesion to other cells or the substrate. Loss of Mbs could reduce the adhesion of epithelial cells to their neighbors, preventing them from withstanding the normal forces involved in axon extension. However, Mbs clones do not show the smooth borders characteristic of changes in adhesive properties (Lee, 2004).
It is not known whether the force generated by excessive myosin activity is located at the growth cone or in the cell body, although the latter model is favored because the highest levels of p-Sqh are found in apical regions of both wild-type and Mbs mutant cells. In vertebrate growth cones, two isoforms of the heavy chain of nonmuscle myosin II seem to have different locations and functions. MHCIIB is more peripheral and is required for axon outgrowth, whereas MHCIIA is central and is required for cell adhesion. Drosophila has only a single zip gene, which may perform both functions. The importance of MHCIIB in generating the traction force that allows growth cone extension suggests that this force might be increased in the absence of MLCP activity. There is a precedent for the idea that axon outgrowth can exert a pulling force on the cell body, because it has been shown that chick motor neurons will migrate out of the spinal cord along their axons if their movement is not blocked by boundary cap cells (Lee, 2004 and references therein).
The other possibility is that the actomyosin contraction takes place within the cell body, detaching it from surrounding cells and pulling it toward the growth cone. This would resemble the normal function of myosin in retracting the rear of migrating cells. Cell detachment and shrinkage has been reported for fibroblasts treated with an inhibitor of MLCP activity. Myosin light chain phosphatase activity may be specifically required in neuronal cells to allow axon extension to occur without triggering a migratory response in the cell body (Lee, 2004).
Reversible phosphorylation of myosin regulatory light chain (MRLC) is a key regulatory mechanism controlling myosin activity and thus regulating the actin/myosin cytoskeleton. We show that Drosophila PP1β, a specific isoform of serine/threonine protein phosphatase 1 (PP1), regulates nonmuscle myosin and that this is the essential role of PP1β. Loss of PP1β leads to increased levels of phosphorylated nonmuscle MRLC (Squash) and actin disorganisation; these phenotypes can be suppressed by reducing the amount of active myosin. Drosophila has two nonmuscle myosin targeting subunits, one of which (MYPT-75D) resembles MYPT3, binds specifically to PP1β, and activates PP1β's Sqh phosphatase activity. Expression of a mutant form of MYPT-75D that is unable to bind PP1 results in elevation of Sqh phosphorylation in vivo and leads to phenotypes that can also be suppressed by reducing the amount of active myosin. The similarity between fly and human PP1β and MYPT genes suggests this role may be conserved (Vereshchagina, 2004).
Nonmuscle myosin II, a molecular motor closely related to vertebrate smooth muscle myosin, powers the actomyosin cytoskeleton. It is required for the coordinated changes in the shape and position of individual cells during morphogenesis as well as for cytokinesis and other cell movements. Nonmuscle myosin II activity is also modulated by metastasis-related and tumor suppressor genes (Vereshchagina, 2004 and references therein).
The regulation of nonmuscle myosin is thought to be broadly similar to that of vertebrate smooth muscle myosin. Contraction and relaxation of vertebrate smooth muscle are regulated by the reversible phosphorylation of myosin regulatory light chain (MRLC), principally on Ser-19. The motor activity of smooth muscle myosin is regulated by the balance of activatory phosphorylation, leading to muscle contraction, and inhibitory dephosphorylation, leading to relaxation. The spectrum of stimulating kinases includes myosin light-chain kinase (MLCK), Rho-associated protein kinase (ROK), p21-associated kinase (PAK), integrin-linked kinase (ILK) and leucine zipper-interacting protein kinase (Dlk/ZIP kinase). The antagonistic protein phosphatase is the catalytic subunit of type 1 serine/threonine protein phosphatase (PP1c) in association with its myosin phosphatase targeting subunit MYPT1 or MYPT2, and a small subunit of unknown function (reviewed by Hartshorne, 1998). These kinases and phosphatases are themselves subject to regulation by reversible phosphorylation, for example ROK not only phosphorylates and activates MRLC, but also phosphorylates MYPT1 and inhibits MRLC dephosphorylation. The nonmuscle roles of these myosin-regulating kinases are less clear, though at least one (ROK) also regulates non-muscle myosin II in both mammals and Drosophila. Similarly, though PP1 is often assumed to be the major non-muscle MRLC phosphatase, PP2A has also been implicated. The various phosphorylation events have been investigated biochemically, but little is known about their physiological significance, particularly in nonmuscle cells (Vereshchagina, 2004 and references therein).
Drosophila nonmuscle myosin II heavy chain zipper (zip) and regulatory light chain spaghetti squash (sqh) are essential for the normal development of a very wide range of cells and tissues. Drosophila Rho-kinase (Drok) phosphorylates both Sqh and DMBS (the single Drosophila homolog of MYPT1/2). By analogy to the vertebrate smooth muscle system it was proposed that this phosphorylation activates myosin and inhibits myosin phosphatase (Vereshchagina, 2004).
PP1 is involved in the regulation of many cellular functions including glycogen metabolism, muscle contraction, and mitosis. In Drosophila, the four genes encoding isoforms of PP1c are named by their chromosome location and subtype: PP1β9C, PP1α13C, PP1α87B, and PP1α96A. Of these, PP1α87B contributes 80% of the total PP1 activity, therefore the phenotypes of PP1α87B loss of function mutants may be due to a loss of overall PP1 activity, rather than identifying specific functions unique to the PP1α87B protein. Mice and humans have three PP1 genes: PP1α and PP1γ are related to the fly PP1α genes, although PP1δ (also known as PP1β) corresponds to fly PP1β. Of the mammalian genes, functional analysis by gene knockout in mice has so far only been performed for PP1γ. This knockout eliminates both the widely expressed PP1γ 1 and the testis-specific PP1γ 2. Homozygous mutant female mice are viable and fertile; homozygous mutant males are viable but sterile, with defects in spermatogenesis. Presumably the somatic and female germline functions of PP1γ are redundant with PP1α and/or PP1δ (Vereshchagina, 2004 and references therein).
The in vitro biochemical activities of the PP1c isoforms are very similar. However, genetic analysis provides a powerful approach to analyze the specific, nonredundant functions of each isoform. The Drosophila PP1β catalytic subunit gene PP1β9C corresponds to flapwing (flw), weak alleles of which are viable but flightless. The semilethality of a strong allele, flw6, demonstrated that PP1β is essential in flies. flw6 larval body wall muscles appeared to form normally, but then detached and degenerated, leading to a semiparalyzed larva that could not feed properly. In addition to muscle defects, the occasional male flw6 survivors were sterile and had blistered wings, indicating a nonredundant role for PP1β9C in nonmuscle cells as well as in muscles (Vereshchagina, 2004).
This study shows that the essential role of PP1β in flies is to regulate nonmuscle actomyosin. The lethality of strong flw (PP1β) mutants is suppressed by reducing the level of phospho-Sqh (MRLC), either using nonphosphorylatable point mutants of sqh or by reducing the gene dosage of key regulators such as Rho1 or RhoGEF2. flw mutants are also suppressed by reducing the gene dosage of nonmuscle myosin heavy chain (zipper). Clones of ovarian follicle cells mutant for flw6 have increased levels of phospho-Sqh, leading to disorganized or absent F-actin and to increased levels of myosin. Therefore, although PP1 isoforms collectively have many known roles, the essential, nonredundant role for PP1β in Drosophila is in the regulation of nonmuscle myosin activity and actin organization (Vereshchagina, 2004).
Drosophila has been reported to have only one MYPT homolog, named DMBS (also known as DMYPT). This study demonstrates that DMBS binds both α and β isoforms of PP1 and is therefore unlikely to mediate a PP1β-specific function. However a Drosophila PP1β-specific regulatory subunit, MYPT-75D, has been identified that is similar to mammalian MYPT3, a prenylated MYPT1/2 paralog. MYPT-75D binds specifically to PP1β in vitro and the two proteins coimmunoprecipitate from fly extracts. MYPT-75D can stimulate PP1β's Sqh phosphatase activity in vitro and MYPT-75D, PP1β and Sqh proteins coimmunoprecipitate. Expression of a nonPP1 binding form of MYPT-75D in flies results in elevation of phospho-Sqh and phenotypic consequences that can be suppressed by reducing the level of Sqh phosphorylation. It is concluded that PP1β is targeted to Sqh by MYPT-75D, where it performs an essential role in the regulation of Sqh phosphorylation, and hence myosin activity, for which other PP1c isoforms cannot substitute. The conservation of all of these components, including the PP1α and β isoforms, suggests that regulation of nonmuscle myosin in mammals may also involve the activity of PP1β and an isoform-specific myosin targeting subunit (Vereshchagina, 2004).
This study shows that two semilethal mutant alleles of PP1β can be dominantly suppressed by loss-of-function extragenic mutations. The existence of single-gene extragenic suppressors indicates that PP1β has a single essential role, the identity of the suppressors indicates that this role is in the regulation of actin and/or myosin. Though the main defect observed in flw mutants is muscle detachment and degeneration, it is clear from these data that it is nonmuscle myosin, rather than muscle myosin, that is affected. Zipper and Sqh are components of nonmuscle myosin; the muscle version of Sqh, Mlc2, does not interact with flw. Similarly, Tm1, but not the muscle-specific Tm2, suppresses flw. Disruption of nonmuscle myosin in flw mutants may lead to disruption of the actin cytoskeleton and affect cell adhesion in many cell types, but seems to be most readily apparent in contractile muscle, particularly the highly specialized indirect flight muscles. Though not directly involved in generation of contractile force, nonmuscle myosin seems to be necessary for the correct development of striated myofibrils (Vereshchagina, 2004).
The dominant suppression of the lethality of flw6 and flw7 mutants by SqhA20A21, coupled with the enhancement of flw1 by SqhE20E21, implies that the essential role of PP1β 9C is related to the regulation of the phosphorylation state of Sqh. To address whether this interaction is direct or indirect, it has been shown that PP1β can directly dephosphorylate phospho-Sqh in vitro and that the two proteins coimmunoprecipitate from Drosophila extracts. Furthermore, a new PP1β-specific MYPT has been identified, and this study shows that binding of MYPT-75D to PP1β stimulates dephosphorylation of nonmuscle MRLC both in vitro and in vivo. It is therefore concluded that the major or only essential role of PP1β in Drosophila is to dephosphorylate Sqh and that this role is mediated, at least in part, by association with a β-specific MYPT protein. Although flw6 behaves as a null allele by genetic tests, the possibility cannot be ruled out that it has some residual activity and that this is sufficient to perform one or more additional essential functions of PP1β, which for some reason require only a very low level of PP1β activity. PP1β, MRLC and MYPT proteins are highly conserved between flies and mammals, so it seems likely that dephosphorylation of MRLC is also an essential role of PP1β in humans (Vereshchagina, 2004).
Though PP1β can dephosphorylate Sqh directly and manipulating the phosphorylation state of Sqh is sufficient to suppress strong mutants of flw, the possibility that flw has other substrates in the same pathway cannot be excluded. For example, nonmuscle myosin heavy chain, which in mammals can be phosphorylated by PKC and CKII, could also be a substrate for PP1β (Vereshchagina, 2004).
What is the molecular basis of the suppression of flw? It is believed that the key defect, both in flw mutants and in flies expressing MYPT-75DF117A, is the hyperphosphorylation of Sqh, particularly on Ser-21; this is directly suppressed by the nonphosphorylatable Sqh mutants. In these experiments a pool of normal Sqh remains, so essentially the ratio of phosphorylated and nonphosphorylated Sqh is being manipulated. Phosphorylation of Sqh leads to activation of the myosin motor; reduction in the amount of myosin heavy chain in zipper+/- presumably reduces the amount of active motor. Sqh is known to be a substrate for Rho-kinase, itself activated by a pathway that includes two more suppressors: Rho1 and RhoGEF2. Rho-kinase itself is located on the X chromosome and was therefore not accessible to the genetic screen (Vereshchagina, 2004).
Tm1, a strong suppressor of flw6, is not a member of Rho-kinase pathway but a cytoskeletal actin-binding protein. Several functions have been ascribed to nonmuscle tropomyosin in mammals: modulation of myosin function, actin polymerization , regulating microfilament branching, and suppression of neoplastic transformation. Reduction in the amount of Tm1 appears to mitigate the consequences of hyper-phosphorylated Sqh; the obvious mechanism is by reducing the binding of active myosin to actin, though Tm1 could have its effect through regulation of actin structure and polymerization (Vereshchagina, 2004).
The phenotypes described for flw somewhat resemble those of DMBS, particularly in the female germ line and in that they both lead to the accumulation of phospho-Sqh, though DMBS mutants do not show the accumulation of myosin aggregates. The differences in lethal phase (embryonic for DMBS, predominantly larval for flw) might be accounted for by maternal contribution and differences in protein stability; it was not possible to investigate this further since both DMBS and flw are required for oogenesis. Furthermore, the flw suppressors sqhA20A21, Rho1 and zipper have been shown or deduced to modify at least some of the DMBS phenotypes. This might indicate that the critical role of flw is mediated by DMBS. However, DMBS is not specific for PP1β. PP1α87B is much more abundant than PP1β, so flw mutants should have little effect on the DMBS: PP1c complex. It is possible that DMBS:PP1β has a unique role not shared by DMBS:PP1α; it is also possible that DMBS, which is phosphorylated by Rho-kinase, is itself directly or indirectly activated by a PP1β-specific phosphatase complex. However, because an additional, PP1β-specific MYPT has been identified, it seems much more likely that this is the key targeting subunit that mediates the essential role of PP1β in vivo and that the suppression of flw by Rho and RhoGEF is through a decrease in phosphorylation of nonmuscle MRLC by Rho-kinase (Vereshchagina, 2004).
Why do flies have two MYPTs apparently doing the same job, one PP1β-specific and the other not? Clearly DMBS is not completely redundant with MYPT-75D, since DMBS mutants are lethal; mutants for MYPT-75D are not available to test the converse. One possible explanation for the presence of multiple myosin targeting subunits in mammals, flies and nematodes lies at the C-termini: MYPT-75D/MYPT3 have a CaaX prenylation motif, whereas DMBS/MYPT1/2 do not. MYPT-75D localizes to the cell periphery; this implies the existence of two different nonmuscle myosin phosphatases in different compartments of the cell: DMBS:PP1c (PP1α or PP1β) in the cytoplasm and MYPT-75D:PP1β at the plasma membrane. These myosin phosphatases have different roles and may be subject to different regulation. However, gross perturbation, such as complete removal of one complex in either DMBS or flw mutants, may lead to hyperphosphorylation of Sqh throughout the cell and hence to similar phenotypic consequences. Similarly, overexpression of the cytoplasmic form at a sufficiently high level may compensate for loss of the membrane-associated form: it was found that overexpression of a DMBS cDNA can suppress flw6, indicating that greatly increased levels of DMBS:PP1α87B can partially compensate for loss of functional MYPT-75D: PP1β9C complexes. A reduction in DMBS gene dose did not enhance flw1, indicating that DMBS is not itself the key targeting subunit for PP1β. Overexpression of MYPT-75D did not suppress flw6, presumably because MYPT-75D is not limiting or because increased levels of a defective MYPT-75D:PP1β9C complex are not helpful. High-level overexpression of MYPT-75D is lethal to wild-type flies, and modest overexpression somewhat reduces the viability of flw1 flies. Both of these results are interpreted as being due to excess MYPT-75D diverting some PP1β from its normal role or location. flw1 flies, in which the MYPT-75D:PP1β9C myosin phosphatase is already somewhat defective, would be predicted to be more sensitive to this effect, as was observed (Vereshchagina, 2004).
In conclusion, PP1β has an essential role, which is in the regulation of nonmuscle myosin, and this can be entirely explained by its role as an MRLC phosphatase. It associates with two different myosin-targeting subunits, one of which is specific for PP1β. These two myosin phosphatases have different roles, though sufficiently high-level expression of the putative cytoplasmic form can partially compensate for loss of the putative membrane-associated form. Loss of PP1β, and hence the PP1β-specific myosin phosphatase, leads to cytoskeletal defects and death, as does loss of the other myosin phosphatase, indicating that each has an important, nonredundant role. All of the components of the system analyzed are well conserved between flies and humans, suggesting that the PP1β-specific myosin phosphatase may also be conserved (Vereshchagina, 2004).
Anillin is a conserved protein required for cytokinesis but its molecular function is unclear. Anillin accumulation at the cleavage furrow is Rho guanine nucleotide exchange factor (GEF)Pbl-dependent but may also be mediated by known anillin interactions with F-actin and myosin II, which are under RhoGEFPbl-dependent control themselves. Microscopy of Drosophila S2 cells reveal here that although myosin II and F-actin do contribute, equatorial anillin localization persists in their absence. Using latrunculin A, the inhibitor of F-actin assembly, a separate RhoGEFPbl-dependent pathway was uncovered that, at the normal time of furrowing, allows stable filamentous structures containing anillin, Rho1, and septins to form directly at the equatorial plasma membrane. These structures associate with microtubule (MT) ends and can still form after MT depolymerization, although they are delocalized under such conditions. Thus, a novel RhoGEFPbl-dependent input promotes the simultaneous association of anillin with the plasma membrane, septins, and MTs, independently of F-actin. It is proposed that such interactions occur dynamically and transiently to promote furrow stability (Hickson, 2008).
Drosophila S2 cell lines expressing anillin-GFP were generatated. The anillin-GFP fusion rescued loss of endogenous anillin and its localization paralleled that of endogenous anillin. In interphase it was nuclear, at metaphase it was uniformly cortical, and in anaphase it accumulated at the equator while being lost from the poles.
In some highly expressing cells, nuclear anillin-GFP formed filaments not ordinarily seen with anillin immunofluorescence, but these disassembled upon nuclear envelope breakdown and the overexpression had no appreciable effect on the progress or success of cytokinesis (Hickson, 2008).
Tests were performed to see whether RhoGEFPbl contributes to anillin localization during cytokinesis. After 3 d of RhoGEFPbl RNAi or Rho1 RNAi, anillin-GFP was found to be localized to the cortex in metaphase but does not relocalize to the equator during anaphase, indicating a requirement for RhoGEFPbl, consistent with prior analysis of fixed RhoGEFPbl mutant embryos. Because anillin can bind F-actin and phosphorylated myosin regulatory light chain (MRLC), RhoGEFPbl might regulate anillin indirectly through its control of F-actin and myosin II (Hickson, 2008).
Latrunculin A (LatA) was used to test whether F-actin was required for anillin-GFP localization. A 30-60-min incubation of 1 µg/ml LatA abolished cortical anillin-GFP localization in metaphase, indicating an F-actin requirement at this phase. However, when anillin normally relocalizes to the equator (~3-4 min after anaphase onset), anillin-GFP formed punctate structures that became progressively more filamentous over the next few minutes, reaching up to several micrometers in length and having a thickness of ~0.3 µm. These linear anillin-containing structures contained barely detectable levels of F-actin and formed specifically at the plasma membrane and preferentially at the equator, although subsequent lateral movement often led to a more random distribution. Thus, anillin responds to spatiotemporal cytokinetic cues even after major disruption of the F-actin cytoskeleton. A substantial (albeit incomplete) reacquisition of cortical phalloidin staining was observed in cells fixed after washing out the drug for a few minutes. In live cells, LatA washout immediately after formation of the anillin structures allowed the preformed structures to migrate from a broad to a compact equatorial zone as the cells attempted to complete cytokinesis. This movement indicates that an F-actin–dependent process can contribute to the equatorial focusing of anillin (Hickson, 2008).
The influence of RhoGEFPbl on anillin behavior was tested in LatA. After RNAi of RhoGEFPbl or Rho1, anillin-GFP remained cytoplasmic through anaphase. Thus RhoGEFPbl and Rho1 are required for anaphase anillin behavior, whether the cortex is intact or disrupted by LatA treatment (Hickson, 2008).
Tests were performed to see whether myosin II impacts anillin-GFP localization. Compared with controls, RNAi of the gene encoding MRLC spaghetti squash (MRLCSqh) inhibited cell elongation during anaphase, slowed furrow formation, and delayed and diminished the equatorial localization of anillin-GFP. However, unlike after RhoGEFPbl RNAi, equatorial accumulation of anillin-GFP was not altogether blocked. It was still recruited but in a broad zone. Furthermore, in the presence of LatA, MRLCSqh RNAi did not affect the formation of the anillin-GFP structures. It is concluded that myosin II contributes to the equatorial focusing of anillin when the F-actin cortex is unperturbed but that myosin II is dispensable for anillin behavior in LatA (Hickson, 2008).
Collectively, these data suggest that multiple RhoGEFPbl-dependent inputs control anillin localization. The slowed equatorial accumulation of anillin when myosin II function was impaired indicates a myosin II-dependent input. That reassembly of the cortical F-actin network (after washout of LatA) allowed preformed anillin structures to move toward the cell equator indicates an F-actin-dependent input. This is consistent with the concerted actions of myosin II and F-actin driving cortical flow, as observed in other cells, and is reminiscent of the coalescence of cortical nodes during contractile ring assembly in Schizosaccharomyces pombe. However, the F-actin- and myosin II-independent behavior of anillin in LatA indicates an additional RhoGEFPbl-dependent input. Thus, RhoGEFPbl can control anillin behavior in anaphase via a previously unrecognized route. Immunofluorescence analysis revealed extensive colocalization between endogenous Rho1 and anillin-GFP in LatA, indicating that Rho1 was itself a component of these structures. These findings are consistent with the idea that Rho1 and anillin directly interact (Hickson, 2008).
Myosin II localization was studied, since it can bind anillin and is controlled by RhoGEFPbl. MRLCSqh-GFP is able to localize to the equatorial membrane independently of F-actin, and in doing so forms filamentous structures resembling those observed with anillin-GFP. Indeed, anillin and MRLCSqh (detected as either MRLCSqh-GFP or with an antibody to serine 21-phosphorylated pMRLCSqh) colocalize (, although they were often offset as if labeling different regions of the same structures (Hickson, 2008).
The effects of anillin RNAi on MRLCSqh-GFP localization were tested. MRLCSqh-GFP recruitment and furrow initiation appeared normal, but within a few minutes of initiation, furrows became laterally unstable and oscillated back and forth across the cell cortex, parallel to the spindle axis, in repeated cycles, each lasting ~1-2 min and eventually subsiding to yield binucleate cells after ~20 min. The phenotype was very similar to that reported for anillin RNAi in HeLa cells and represents a requirement for anillin at an earlier stage than previously noted in Drosophila. Thus, a conserved function of anillin is to maintain furrow positioning during ingression (Hickson, 2008).
<{>In LatA, anillin RNAi did not prevent equatorial MRLCSqh-GFP recruitment, but instead of appearing as persistent linear structures distorting the cell surface, a more reticular and dynamic structure lacking cell surface protrusions was observed. Thus myosin II can localize independently of both anillin and F-actin but the filamentous appearance of myosin II in the presence of LatA requires anillin, indicating that anillin can influence myosin II behavior in the absence of F-actin, whereas myosin II appeared capable of influencing anillin behavior only in the presence of F-actin (Hickson, 2008).
Septins are multimeric filament-forming proteins that can bind anillin in vitro and function with anillin in vivo. Using an antibody to the septin Peanut, it was found that in nontransfected S2 cells, septinPnut localized to the cleavage furrow and midbody where it colocalized with anillin. Unexpectedly, the septinPnut antibody also strongly labeled bundles of cytoplasmic ordered cylindrical structures, each ~0.6 µm in diameter and of variable length (up to several micrometers). These staining patterns could be greatly reduced by septinPnut RNAi and were thus specific. The cylindrical structures did not appear to be cell cycle regulated, as they were apparent in interphase, mitotic, and postmitotic cells. They also did not colocalize with anillin, nor did their stability rely on anillin. Incubation with 1 µg/ml LatA before fixation inevitably led to disassembly of most of these large structures; however, the resulting distribution of septinPnut depended on the cell cycle phase. In LatA-treated interphase cells, when anillin is nuclear, septinPnut formed cytoplasmic rings, ~0.6 µm in diameter, which are similar to the Septin2 rings seen in interphase mammalian cells treated with F-actin drugs or in the cell body of unperturbed ruffling cells (Kinoshita, 2002; Schmidt, 2004). In LatA-treated mitotic cells, septinPnut was diffusely cytoplasmic (or barely detectable) in early mitosis, whereas in anaphase/telophase, it localized to the same plasma membrane-associated anillin-containing filamentous structures (Hickson, 2008).
Anillin behavior was analyzed after septinPnut RNAi. Although unable to fully deplete septinPnut, it was found that anillin could localize to the equatorial cortex in regions devoid of detectable septinPnut, which is consistent with findings in C. elegans (Maddox, 2005). Importantly, in septinPnut-depleted cells, anillin-GFP still localized to the plasma membrane in LatA but no longer appeared filamentous, indicating that septinPnut is essential for the filamentous nature of the structures and that Rho1 can promote the association of anillin with the plasma membrane independently of septinPnut. However, in this case the plasma membrane to which anillin-GFP localized subsequently exhibited unusual behavior. It was internalized in large vesicular structures, apparently in association with midzone MTs. Although this phenomenon is not understood, it may be related to events induced by point mutations in the septin-interacting region of anillin that give rise to abnormal vesicularized plasma membranes during Drosophila cellularization (Hickson, 2008).
The effects were tested of anillin RNAi on the localization of septinPnut. Using Dia as a furrow marker, 3 d of anillin RNAi prevented the furrow recruitment of septinPnut. In LatA-treated cells, anillin RNAi did not affect the formation of septinPnut rings in interphase cells, but it greatly reduced the formation of septinPnut-containing structures during anaphase/telophase. Thus, anillin is required for the furrow recruitment of septinPnut and for the formation of septinPnut-containing structures in 1 µg/ml LatA. In contrast, Dia could still localize to the equatorial plasma membrane after combined anillin RNAi and LatA treatment, indicating that it can localize independently of both anillin and F-actin. Thus, although Dia partially colocalized with anillin in LatA, this likely reflected independent targeting to the same location rather than an association between anillin and Dia (Hickson, 2008).
These data argue that Rho1, anillin, septins, and the plasma membrane participate independently of F-actin in the formation of a complex. However, anillin, septins and F-actin can also form a different complex in vitro, independently of Rho (Kinoshita, 2002). Perhaps two such complexes dynamically interchange in vivo (Hickson, 2008).
The involvement of MTs in anillin behavior was tested in LatA. Overnight incubation with 25 µM colchicine effectively depolymerized all MTs in mitotic cells and promoted mitotic arrest, as expected. Using Mad2 RNAi to bypass the arrest, anillin-GFP was observed during mitotic exit in the absence of MTs and in the presence of LatA.
Under such conditions, anillin-GFP formed filamentous structures very similar to those formed when MTs were present, indicating that MTs were dispensable for their formation. However, the structures appeared uniformly around the plasma membrane rather than restricted to the equatorial region, which is consistent with the role MTs play in the spatial control of Rho activation (Hickson, 2008).
The LatA-induced anillin structures localize to the ends of nonoverlapping astral MTs directed toward the equator. Live imaging of cells coexpressing cherry-tubulin and anillin-GFP revealed bundles of MTs associating with the filamentous anillin-GFP structures as they formed. Colocalization between anillin-GFP structures and MT ends persisted over many minutes, even after considerable lateral movement at the membrane. Thus, although the anillin structures formed independently of MTs, they stably associated with MTs. These findings support prior biochemical evidence for interactions of MTs with both anillin and septins (Sisson, 2000) and reveal a potential positive-feedback loop in which MTs directed where Rho1-anillin-septin formed linear structures at the plasma membrane, whereas the structures in turn associated with the MT ends. An MT plus end-binding ability of anillin-septin could explain the furrow instability phenotype elicited by anillin RNAi. Accordingly, anillin may physically link Rho1 to MT plus ends during furrow ingression, thereby promoting the focusing and retention of active Rho1, thus stabilizing the furrow at the equator (Hickson, 2008).
These live-cell analyses highlight an unusual behavior of the Rho-dependent anillin-containing structures at the plasma membrane. Initially forming beneath and parallel to the plasma membrane, the structures then often lifted on one side to appear perpendicular to the cell surface while remaining anchored at their base by MTs. This reorientation is interpreted as reflecting avid binding to and subsequent envelopment by the plasma membrane. Although intrinsically stable, the structures exhibited dynamic movement within the plane of the plasma membrane and were capable of sticking to one another, via their ends, giving rise to branched structures that were also capable of breaking apart. Anillin has a pleckstrin homology domain within its septin-interacting region and a membrane-anchoring role of anillin has long been postulated (Field, 1995). These data support such a role and suggest that it is controlled by Rho (Hickson, 2008).
The data highlight the complexity of RhoGEFPbl signaling and lead to a model in which multiple Rho-dependent inputs synergize to control anillin behavior during cytokinesis (Hickson, 2008).
At the appropriate time and lo